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 ABSTRACT 
 
Phosphatidylserine (PS) lipids in cell membranes play significant roles in cell 
apoptosis, blood clotting and neurodegenerative disorders such as Alzheimer’s disease 
(AD). A novel fluorescence quenching assay based on lipid bilayer-coated microfluidic 
platform was developed to investigate the interactions of PS, Cu
2+
 and PS-related 
proteins on membranes. PS in supported lipid bilayers (SLBs) was found to bind Cu
2+
 
and the resulting Cu(PS)2 complex could quench a broad spectrum of lipid-bound 
fluorophores in a reversible and pH-dependent fashion.  
This quenching assay was subsequently combined with other spectroscopy 
techniques to explore how Cu
2+
-binding affinity changes as a function of PS surface 
density. The apparent binding affinity of Cu
2+ 
to PS got enhanced by about five orders of 
magnitude as the PS density in SLBs was increased from 1.0 to 20 mol %. Despite the 
effect of binding valency change from monovalent to bivalent, this binding enhancement 
was primarily attributed to the greatly amplified Cu
2+
 concentration in the double layer 
of the surface with a high PS density, since Cu
2+
-binding preserves the surface charges.  
Cu
2+
-PS interactions have numerous biological implications under specific 
physiological or pathological conditions. Herein two typical examples were investigated. 
First one involves the interactions of β-amyloid peptides (Aβ), Cu2+ and lipid 
membranes. Aβ is an important biomarker of Alzheimer’s disease (AD) while Aβ-
binding of transition metal ions can promote its pathological assembly. We applied our 
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fluorescence assay and mass spectrometry (MS) to mimic how Aβ acquires Cu2+ from 
cell membranes in AD brains where copper level is generally reported to be depressed. 
The Cu
2+
 detachment by Aβ was detected by monitoring the recovery of the fluorescent 
signal quenched by Cu(PS)2 complex. This Cu
2+
 transfer behavior can be confirmed by 
MS detection of different complexes. The results could assist clarifying the membrane-
related neurotoxicity of Aβ and copper homeostasis at pathological conditions. The 
combination of fluorescence and MS can be further applied in investigations of other 
Cu
2+
-mediated interactions between proteins and membranes. Another biological 
implication is about the effect of Cu
2+
-PS binding on lipid oxidations. With PS in 
vesicles, the oxidation of surrounding unsaturated phosphatidylcholine (PC) lipids was 
inhibited, which implies that PS in the membranes might protect other lipids against the 
Cu
2+
-catalyzed oxidation.   
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NOMENCLATURE 
 
SLBs                     Supported Lipid Bilayers  
SUVs                    Small Unilamellar Vesicles 
PDMS                 Polydimethylsiloxane 
POPC                  1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine 
POPS                   1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-L-serine 
DOPS                   1,2-dioleoyl-sn-glycero-3-phospho-L-serine 
DLPS                    1,2-dilauroyl-sn-glycero-3-phospho-L-serine 
DPPS                    1,2-dipalmitoyl-sn-glycero-3-phospho-L-serine 
GM1                      Ganglioside (bovine)  
Cardiolipin           1,1',2,2'-tetramyristoyl cardiolipin 
DOPG                   1,2-dioleoyl-sn-glycero-3-phospho-(1'-rac-glycerol) 
DPPG                    1,2-dipalmitoyl-sn-glycero-3-phospho-(1'-rac-glycerol) 
POPG  1- palmitoyl-2-oleoyl-sn-glycero-3-phospho-(1’-rac-
glycerol) 
DOPA                   1,2-dioleoyl-sn-glycero-3-phosphate   
DSPA                    1,2-distearoyl-sn-glycero-3-phosphate 
TR-DHPE  Texas Red 1,2-dihexadecanoyl-sn-glycero-3-
phosphoethanolamine 
Tail-labeled NBD-PC 1-palmitoyl-2-{12-[(7-nitro-2-1,3-benzoxadiazol-4-
yl)amino]dode-canoyl}-sn-glycero-3-phosphocholine 
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Tail-labeled NBD-PS 1-palmitoyl-2-{12-[(7-nitro-2-1,3-benzoxadiazol-4-
yl)amino]dode-canoyl}-sn-glycero-3-phosphoserine 
Head-labeled NBD-PS 1,2-dioleoyl-sn-glycero-3-phospho-L-serine-N-(7-nitro-2-
1,3-benzoxadiazol-4-yl)  
Rhodamine-DHPE  Lissamine Rhodamine B 1,2-dihexadecanoyl-sn-glycero-
3-phosphoethanolamine 
Fluorescein-DHPE  N-(Fluorescein-5-thiocarbamoyl)-1,2-dihexadecanoyl-sn-
glycero-3-phosphoethanolamine 
Bodipy-DHPE  N-(4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-diaza-s-
indacene-3-propionyl)-1,2-dihexadecanoyl-sn-glycero-3-
phosphoethanolamine  
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CHAPTER I 
INTRODUCTION 
 
Cell Membranes and Supported Lipid Bilayers  
 
Cell membranes play crucial roles in a lot of fundamental biological processes. 
They usually consist of the lipid bilayer as a core structure and the associated functional 
proteins such as integral proteins and peripheral proteins.
1
 In mammalian cells, 
glycerophospholipids are the main components of the membranes, which account for 
about 70% of the total lipid content, while the other 30% are cholesterol, sphingomyelin, 
and glycosphingolipids.
2
 Differences in lipid compositions in general will affect the 
charge density and permeability of cell membranes. Specifically, certain lipids are 
involved in the protein-membrane binding, cell signaling and biosynthetic pathways 
while the malfunctions of these processes are closely related to diseases.
2-4
 Therefore, it 
is necessary to achieve a better understanding of the properties and functions of specific 
lipids to further elucidate the molecular basis of those biological events and facilitate the 
discovery of new therapeutics.  
Supported lipid bilayers (SLBs) have been well recognized as model systems to 
study the properties of cell membranes and the protein-membrane interactions.
5-8
 
Compared with black lipid membranes or suspended lipid membranes, SLBs are 
superior in their stability and more accessible to the surface characterization techniques
 
 
2 
 
such as atomic force microscope (AFM), fluorescence microscope and quartz crystal 
microbalance (QCM), due to the immobilization of the analytes on the solid surface.
9-12
 
Furthermore, the two-dimensional membrane fluidity is maintained in SLBs owing to a 
10~20 Å layer of trapped water lubricant between the solid substrate and the bilayers.
6,13
 
Therefore, the redistribution and reorganization of the surface constituent are attainable, 
which allows for the investigations of multivalent ligand-receptor interactions, cell 
signaling and lipid trafficking. For example, a pentavalent carbohydrate-protein 
interaction on membranes, the ganglioside GM1 binding of cholera toxin B-subunit 
(CTB), has been explored on SLBs in microfluidic devices.
9
 The results surprisingly 
showed a 10-fold weaker binding affinity as the GM1 density was increased from 0.02 to 
10.0 mol %. This inhibition of CTB binding on GM1-enriched membranes is caused by 
the hydrogen-bonding interactions between adjacent glycolipid headgroups, resulting in 
the clustering of GM1 which disturbs the binding.
9,14
 During this study, the fluidic lipid 
bilayers formed on glass surface provide an applicable ligand presentation platform 
which can be visualized by fluorescence microscope and AFM.  
SLBs can be formed on a variety of solid substrates, such as glass, quartz, mica, 
gold and titanium oxide.
6,12,15-17
 Three methods are generally used to form SLBs.
6
 The 
first approach is vesicle adsorption and fusion. After incubating with the solid support, 
lipid vesicles in aqueous solutions can spontaneously adhere to the substrate and fuse to 
form the lipid bilayers.
18
 The second way is through a layer-by-layer lipid deposition on 
solid surface based on Langmuir-Blodgett technology.
13
 Additionally, a combinative 
method can be applied, in which a monolayer is firstly transferred to the surface via 
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Langmuir–Blodgett method followed by vesicle fusion to form the upper layer of 
SLBs.
19
 The first method is easier and more versatile while the other two are usually 
employed to form asymmetric SLBs.
6
  
 
Properties and Biological Functions of Phosphatidylserine Lipids and Copper Ions  
 
Phosphatidylserine (PS) is one of the most abundant negatively charged 
phospholipids in cell membranes (structure shown in Figure 1.1).
2
 It can be found in a 
variety of cells and plays an important role in apoptosis, blood clotting and embryonic 
development, which can be attributed to its unique physical and biochemical 
identities.
2,20-23
 PS density varies significantly throughout various cellular membranes 
and moreover, PS lipids are asymmetrically distributed between two leaflets of an 
individual membrane bilayer.
2
 For example, PS preferentially resides in the cytoplasmic 
leaflet of plasma membrane due to the action of aminophospholipid flippases, whereas 
the translocation of PS from the inner to outer leaflet is usually associated with cell 
apoptosis.
2,21,24
 Carrying one negative charge at physiological pH, PS is known to form 
complexes with metal ions such as Ca
2+
 and Mg
2+ 
through the carboxyl and phosphate 
groups.
25-29
 These interactions are assumed to be relatively weak with equilibrium 
dissociation constants generally measured in mM~M range.
25,28,30
 Despite an abundance 
of studies on Ca
2+
-PS binding, there is far less known about how transition metal ions 
interact with PS.
26,31
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Figure 1.1. The structure of phosphatidylserine (PS) lipid 
 
Transition metal ions are essential for the activities of various enzymes and 
influence a number of medically relevant events.
32,33
 Copper is the third most abundant 
transition metal in human body and it is redox-active.
32
 Generally, the distribution of 
copper ions within cells is strictly regulated by enzymes and chaperons while the labile 
Cu
2+
 is toxic to cells and closely linked to neurodegenerative disorders such as Wilson’s 
disease and Alzheimer’s disease.33,34 However, many questions still remain concerning 
copper ion homeostasis and how it contributes to disease.  
Cu
2+
 is generally found to bind negatively charged residues of proteins as well as 
the lone electron pairs of nitrogen on histidine, lysine, arginine and N-terminus.
35-38
 
Decades ago, in an initiative study, Cu
2+
 was found to form a complex with PS in 1:2 
ratio at the interface of organic/aqueous solution.
26
 Further studies indicated that Cu
2+
-
PS interactions have numerous biological implications, such as the PS-dependent 
protein-membrane binding and the oxidative damage of cell membranes.
2,39
 The 
consequences of these interactions are probably more pronounced when PS lipids are 
flipped from the inner to outer leaflets of plasma membranes during apoptosis or other 
biological processes, which increase the exposed PS density on cell membranes and 
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enable the direct contact of PS with a Cu
2+
-rich environment.
24,40
 Therefore, it is 
appealing to study the properties and functions of Cu
2+
-PS binding in these biological 
events. Previous studies of Cu
2+
-PS focused upon detecting the effect of divalent cations 
(Ca
2+
 and/or Cu
2+
) binding on molecular motions of PS in a water-methanol-chloroform 
mixed solvent.
26
 However, Cu
2+
-PS interactions had only been characterized with mM 
Cu
2+
 concentrations using atomic absorption spectroscopy (AAS) and electron spin 
resonance spectroscopy (ESR).
26
 This inspired us to develop a generally applicable and 
more sensitive fluorescence-based assay which allows us to detect physiological levels 
of Cu
2+
 and investigate the interactions of Cu
2+
 and the negatively-charged PS on lipid 
bilayers.  
 
Detecting Ligand-Receptor Interactions by Fluorescent Sensing on Microfluidic 
Platform Combined with Other Analytical Techniques 
 
Ligand-receptor interactions are essential to various biological processes 
including cell signaling, pathogen recognition and inflammatory response.
3,41
 
Understanding these interactions on a molecular basis and how they are associated with 
membrane chemistry should provide insights into the elucidation of biological processes 
and the targeted drug design. Fluorescence sensing methods based on microfluidic 
devices have been established by our group to investigate the ligand–receptor 
interactions on lipid membranes.
42,43
 This lab-on-a-chip technique on a microfluidic 
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platform allows for a rapid, high-throughput and low-sample-volume analysis with an 
unprecedented signal-to-noise ratio.  
The microfluidic devices are fabricated from oxygen plasma-cleaned 
polydimethylsiloxane (PDMS) patterns and annealed glass coverslips. After loading the 
small unilamellar vesicles (SUVs) into each of the channels in microfluidic devices and 
incubating them for thirty minutes, the lipid bilayers can be formed through vesicle 
adsorption and fusion.
44,45
 Incorporating lipid-bound fluorophores into the lipid bilayers 
enables us to visualize parallel channels and create a real-time in situ detection on the 
SLBs. The buffer solutions containing proteins, drug molecules or metal ions can be 
continuously introduced to the lipid bilayers through a gravity-driven flowing method 
(Figure 1.2). The equilibrium can be established quickly at high sample concentrations 
while it might take as long as several hours for samples in low concentrations (pM~nM) 
to reach equilibrium. Usually, only microliters to milliliters of samples are required for 
the detection. The data from lipid bilayers with different lipid compositions or protein 
concentrations can be acquired simultaneously in multiple channels to generate binding 
curves.  
This fluorescence method can be combined with other analytical techniques to 
address the research questions and provide more in-depth information for ligand-
receptor interactions. In this dissertation, several other spectroscopy techniques such as 
dynamic light scattering (DLS), ultraviolet–visible spectroscopy (UV/Vis), fluorometry 
and vibrational sum-frequency spectroscopy (VSFS) were employed in different projects. 
For example, VSFS based on sum frequency generation (SFG) was used to elucidate 
 
 
7 
 
surface-specific water molecules at a lipid monolayer/water interface involving cation-
lipid interactions and measure the surface charges.
46-48
 Besides, electrospray ionization 
mass spectrometry (ESI-MS) and liquid chromatography–mass spectrometry (LC-MS) 
also play big parts in the studies into ion-lipid and ion-peptide binding as well as the 
lipid oxidation chemistry. Given the ability of ESI-MS to manipulate large molecular 
ions through soft ionization mode, the binding complexes can be examined in a straight-
forward way to confirm their structures and stoichiometry.
49,50
 The lipid oxidation 
products at different conditions can be quantatively measured by LC-MS, which helps us 
to investigate if these metal ion-lipid interactions can promote or disrupt the oxidation 
damage of the membranes.
51
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Figure 1.2. Schematic representation of the fluorescence sensing experiments set up on 
microfluidic devices. The microfluidic device consisted of a patterned PDMS block 
adhered to a glass coverslip. Top view of the device was shown in the right top, as well 
as a typical fluorescent image obtained from lipid bilayers in multiple channels. The 
fabrication procedure for the device was described in the experimental section in 
Chapter II. For binding detections, buffer solutions containing proteins, metal ions or 
drug molecules were flowed into each channel by several Teflon tubes through each inlet 
port to interact with SLBs. Flow through the device was gravity driven with an average 
flow rate at ~100 μL/h in each channel. The consumed buffer drained from each outlet 
port to waste container. The fluorescence of each channel was monitored by an inverted 
epifluorescence microscope. 
 
 
*Reprinted with permission from “Phosphatidylserine Reversibly Binds Cu2+ with Extremely 
High Affinity” by Monson, C. F.; Cong, X.; Robison, A. D.; Pace, H. P.; Liu, C. M.; Poyton, M. 
F.; Cremer, P. S. Journal of the American Chemical Society 2012, 134, 7773. Copyright 2012 by 
American Chemical Society.   
                                                                        9  
CHAPTER II 
DEVELOPING A FLUORESCENCE QUENCHING ASSAY FOR THE DETECTION 
OF PHOSPHATIDYLSERINE- Cu
2+
 INTERACTIONS* 
 
Introduction 
 
Phosphatidylserine (PS) lipids are found in a wide variety of cell types, but are 
typically only present in moderate abundance. In eukaryotic systems, they account for 
approximately 5-10 mol % of phospholipid content.
2
 Moreover, PS is unevenly 
distributed within cells. For example, it is enriched in the inner leaflet of the plasma 
membrane and depleted in the outer leaflet.
2,20
 It is essentially absent in mitochondrial 
membranes.
2,52
 A number of proteins interact specifically with PS and it is an important 
signaling molecule in clotting, apoptosis, and embryonic development.
2,23,53-57
 PS bears a 
negative charge at physiological pH and is known to form complexes with metal ions 
such as Ca
2+
, Mg
2+
 and Cu
2+
.
25,58,59
 These interactions are assumed to be relatively weak 
with equilibrium dissociation constants that have been generally measured in the mM 
range for Ca
2+
. The presence of Ca
2+
 mediates a number of protein-PS interactions and 
therefore the Ca
2+
-PS interaction has been relatively well studied.
25,60-63
 There have been 
far fewer investigations of Cu
2+
-PS interactions, although it is known that at mM 
concentrations Cu
2+
 forms a 1:2 complex with PS in solutions containing water, 
methanol, and chloroform.
59
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Cu
2+
 is necessary for the proper activity of various enzymes, but uncomplexed 
Cu
2+
 is toxic to cells.
64,65
 Indeed, in healthy cells the total copper ion concentration is 
generally around 100 μM, but the free copper ion concentration is so low that on average 
there is less than one free ion per cell.
66
 Thus, copper
 
is tightly regulated with copper 
chaperones responsible for the delivery of copper ions to copper-binding enzymes and 
the vast majority of the copper delivery is in the form of Cu
+
.
65,67
 Excessive copper has 
been linked to Wilson’s disease and a number of medically relevant events are 
influenced by copper ions, including the outcome of vascular injury and the onset of 
prion disease.
68,69
 Cu
2+
 has also been proposed for use as an anti-tumor agent.
70
  
Using a fluorescence quenching assay, we report herein that PS binds Cu
2+
 on 
lipid bilayers in a reversible fashion. The Cu
2+
-PS system forms a one metal ion-to-two 
PS lipid complex and is observed to quench a variety of lipid-bound fluorophores as 
illustrated schematically in Figure 2.1. Fluorescence quenching takes place at basic pH 
values and unquenching occurs under acidic conditions. The 1:2 Cu
2+
-PS complex has a 
number of implications for biological processes. For example, the PS-enriched inner 
plasma membrane may serve as a Cu
2+
 scavenger or as a location for copper-dependent 
reactions at high environmental Cu
2+
 levels. 
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Figure 2.1. The PS-mediated Cu
2+
 quenching reaction. At basic pH values, Cu
2+
 binds to 
2 PS molecules and quenches nearby fluorophores (red to black in the diagram). The 
reaction can be reversed by lowering the pH.  
 
Experimental Section 
 
Vesicle Preparation 
Phospholipid vesicles were prepared using the freeze-thaw/extrusion method.
71,72
 
Lipids were mixed in chloroform at the desired ratio and then the chloroform was 
evaporated in a stream of N2 gas. The dried lipids were put under vacuum for at least 
four hours to remove any remaining solvent. The lipid mixture was rehydrated with Tris 
buffer (100 mM NaCl, 10 mM tris(hydroxymethyl)aminomethane, pH 7.4), subjected to 
ten freeze/thaw cycles in liquid nitrogen and warm water, and then extruded through a 
track etched polycarbonate membrane with 100 nm pores (Whatman, Florham Park, NJ). 
The vesicles were diluted to 1 mg/mL with Tris buffer and stored at 4 °C until use. The 
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average size of the vesicles was found to be 100 ± 20 nm by dynamic light scattering 
(90Plus Particle Size Analyzer, Brookhaven Instrument Corp., Holtsville, NY). 
 
Glass Cleaning 
Glass coverslips (Corning, Inc., Corning, NY, 24 x 40 mm No. 1.5) were cleaned 
by boiling in a 1:5 solution of 7X (MP Biomedicals, Solon, OH) and purified water. The 
slides were extensively rinsed with 18 MΩ water (Barnstead Nanopure water 
purification system, Thermo Scientific), blown dry with filtered air, and annealed at 
530 °C for five hours.
42
  
 
Microfluidic Fabrication 
Microfluidic devices were fabricated from polydimethylsiloxane (PDMS, 
Sylgard 184, Dow Corning, Midland, MI) and clean glass coverslips using previously 
reported procedures.
42
 Briefly, HF etching was performed on a glass plate protected by 
photolithographically patterned photoresist (MICROPOSIT S1813, Shipley Corp. 
Marlborough, MA) to form a master. PDMS was mixed in a 10 part base to 1 part 
polymerizer mass ratio, degassed under vacuum for 1 hour, poured over the master, and 
baked at 100 °C for 2 hours. Access holes were punched with a polished needle. The 
devices were assembled by pressing together an oxygen plasma-cleaned PDMS body 
and an oxygen plasma-cleaned glass cover slip and heating to 100 °C for 1 minute. 
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Bilayer Formation  
SLBs were formed via the vesicle fusion method.
73-75
 Fourteen microliters of 
vesicle solution were injected via a pipette into each channel of a freshly prepared 
microfluidic device. In all runs, the largest lipid component of the vesicles was 1-
palmitoyl-2-oleoyl-sn-glyero-3-phosphocholine (POPC, Avanti Polar Lipids, Alabaster, 
AL). A fluorescent lipid was also present, typically Texas Red 1,2-dihexadecanoyl-sn-
glycero-3-phosphoethanolamine (TR-DHPE, Invitrogen, Carlsbad, CA) at either 0.1 or 
1.0 mol % along with 0 to 30 mol % PS. 1,2-dioleoyl-sn-glycero-3-phospho-L-serine 
(DOPS, Avanti Polar Lipids, Alabaster, AL) was the PS species used in all experiments 
unless otherwise noted. The vesicles spontaneously fused to the cleaned glass slides to 
form continuous SLBs. After a thirty minute incubation time, the channels were rinsed 
by gravity driven buffer flow for one hour to remove any remaining vesicles and 
experiments were subsequently commenced. 
 
Microfluidic Procedure  
Five to seven supply tubes (0.6 mm internal diameter Teflon tubing, SPC 
Technology) brought buffer from a reservoir to the individual microfluidic channels of 
the PDMS/glass device and the consumed buffer drained to a waste container (Figure 
1.2). Flow through the device was gravity driven with an average flow rate on the order 
of 200 μL/hour in each microfluidic channel. The total buffer consumption rates were on 
the order of 10 mL/hour when the buffer was being exchanged. Tris, phosphate, and 
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citrate buffers were tested to ensure the independence of the observed quenching 
reaction by specific buffers. Similar behavior was observed with each buffer. 
For the flow cell experiments shown in this work, a universal buffer consisting of 
a 2:1:2 molar ratio of sodium citrate:MES (2-(N-morpholino)ethanesulfonic acid):Tris 
was used.
76
 The buffer was adjusted to the desired pH value with NaOH and HCl. Most 
buffers were run at 1 mM total buffer concentration with only trace amounts of CuSO4 
and no other salts present. CuSO4 and CuCl2 salts were both tested as sources of Cu
2+
 
and no difference was observed in the quenching reaction. Buffer was constantly flowed 
through the channels during all experiments. When the buffer reservoir solution was 
exchanged, there was a lag time of a few minutes before the fluorescence intensities 
inside the microchannels began to change. This was due to the dead volume in the tubing 
between the container and the microfluidic device. The fluorescence of the channels was 
intermittently observed until equilibrium was reached. When low CuSO4 concentrations 
were employed (pM and below), several hours were required for equilibrium to be 
established. 
 
Vesicle Titration Measurements  
Fluorescence measurements at constant Cu
2+
 concentrations were recorded in a 
QE 65000-FL Scientific Grade Spectrometer with a DH-2000 Deuterium Tungsten 
Halogen Light Source (Ocean Optics, Dunedin, FL). The lipid mixture with 1 mol % 
TR-DHPE and 15 mol % DOPS in POPC was mixed in chloroform and dried with 
flowing N2 and vacuum. It was then rehydrated with Tris/NaCl buffer (10 mM Tris, 100 
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mM NaCl, pH 7.4) containing serial concentrations of CuSO4 ranging from 0 to 43 µM. 
This was followed by ten freeze/thaw cycles in liquid nitrogen and warm water. Finally, 
the vesicles were extruded through a track etched polycarbonate membrane with 100 nm 
pores (Whatman, Florham Park, NJ). In this way, CuSO4 should be distributed both 
inside and outside the vesicles, which is important to insure that fluorophores on both 
leaflets can be accessed by Cu
2+
. Fluorescence measurements were performed with 1.5 
mL aliquots of these 100 nm vesicle solutions at 0.17 mg/mL.  
 
Results 
 
Cu
2+
-PS Binding in Flowing Buffer inside Microfluidic Channels 
In a first set of experiments, fluorescence imaging of supported lipid bilayers was 
performed in two parallel microfluidic channels. The bilayers contained 0.1 mol % TR-
DHPE and were interrogated at pH 3.6 and 8.0 in the presence and absence of 800 pM 
CuSO4 (Figure 2.2). The left channel of each channel pair contained no PS, while the 
right channel had 20 mol% PS in the bilayer. As can be seen, the fluorescence intensity 
was uniform under most conditions. However, in the presence of both PS and Cu
2+
 the 
fluorescent response of the TR-DHPE was quenched by a factor of 5 under basic 
conditions. If any one of the three necessary components (PS, Cu
2+
, and basic pH) for 
quenching were missing, very little or no quenching was observed. As will be explored 
below, the quenching was the result of Cu
2+
-PS complex formation, as illustrated in 
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Figure 2.1. The complex localized Cu
2+
 near the bilayer surface, which in turn quenched 
the fluorophore.  
 
 
Figure 2.2. Fluorescence images from parallel lipid bilayers in a microfluidic device. (A) 
Fluorescence images and (B) line scans from microfluidic devices when no DOPS (left 
channel) and 20 mol% DOPS (right channel) were present in SLBs along with 0.1 mol % 
TR-DHPE. The fluorescence is shown in the presence and absence of 800 pM CuSO4 at 
both pH 3.6 and 8.0 with 1 mM citrate/MES/Tris buffer. The increased fluorescence 
intensity observed on the sides of the channels in the line scans with the 20 mol% DOPS 
channel is an edge effect from where the glass floor of the microchannels met the PDMS 
walls.
77
 
 
3.6 8.0
0 pM
0
 P
S
2
0
%
 P
S
pH:
800 pM
0
 P
S
2
0
%
 P
S
0
 P
S
2
0
%
 P
S
0
 P
S
2
0
%
 P
S
0 pM 800 pMCu2+:
A
0
50
100
150
200
250
300
0 100 200 300 400 500
Position (m)
F
lu
o
r.
 I
n
te
n
s
.
pH 3.6, 0 Cu2+ pH 8.0, 0 Cu2+
pH 3.6, 800 pM Cu2+ pH 8.0, 800 pM Cu2+
B
0 PS 20% PS
 . , 0 u2+
 . , 00 pM Cu2+  . , 00 pM Cu2+
 . ,  u2+
0
 P
S
2
0
%
 P
S
0
 P
S
2
0
%
 P
S
0
 P
S
2
0
%
 P
S
0
 P
S
2
0
%
 P
S
F
lu
o
r.
 I
n
te
n
s
.
 
 
17 
 
To explore the pH response of this process, the pH of the buffer flowing over the 
SLBs was varied between pH 3 and pH 10 with 800 pM CuSO4 and the DOPS 
concentration in the SLBs was varied from 0 to 30 mol % (Figure 2.3A). Each data set 
was normalized to its own maximum intensity over the pH range to better illustrate the 
pH at which the fluorescence began to be quenched at a given amount of DOPS. The 
midpoint of the titration curve occurred near pH 5.5 when 30 mol% DOPS was present. 
This titration point shifted to higher pH and became much less pronounced as the 
concentration of DOPS was lowered. Also, at a given pH, increasing the amount of PS in 
the SLB increased the quenching that occurred. The dye employed in these experiments, 
TR-DHPE, consisted of ortho and para isomers. The ortho dye, which is usually no 
more than a quarter of the mixture, is reversibly quenched at basic pH values.
77
 This 
accounts for a small decrease in fluorescent signal observed at pH 10.5 even in the 
absence of DOPS. Moreover, it should be noted that dequenching occurred above pH 11.  
This is due to the formation of a copper hydroxide complex, most likely [Cu(OH)4]
2-
.
78
 
Stern-Volmer plots in Figure 2.3A show near linear dependence as the DOPS 
concentration was increased until at least 20 mol % DOPS (Figure 2.3B). F0 was the 
fluorescence intensity when no quencher was added and F was the observed 
fluorescence intensity at the indicated quencher concentration. In this and subsequent 
figures, the error bars represent the standard deviation of multiple measurements. The 
fluorescence increase became somewhat nonlinear above 20 mol % DOPS at pH 9.0. 
This may be because essentially all of the TR-DHPE molecules could already be 
quenched with just 20 mol % DOPS. The quenching constant (slope of the line) 
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increased with increasing pH, but even at relatively acidic pH values there was modest 
quenching of the TR-DHPE. Of course, the degree of quenching can also be seen to 
diminish as the DOPS concentration was lowered, which is consistent with a greater 
average distance between Cu
2+
-PS complexes and TR-DHPE molecules under these 
conditions. Control experiments using UV-visible spectroscopy demonstrated that 
quenching occurs under conditions where the adsorption of the fluorophore neither shifts 
nor attenuates (Figure 2.4). As such, a dynamic rather than a static quenching 
mechanism should be involved.
79,80 
 
Figure 2.3. The Cu
2+
-PS quenching response as a function of pH. In (A) the 
fluorescence intensity is shown as a function of pH. In (B) a Stern-Volmer plot of the 
data is shown at pH 3.6, 6.9, and 9.0. Both plots are for SLBs consisting of 1.0 mol % 
TR-DHPE and 0 to 30 mol % DOPS in POPC with a 1 mM citrate/MES/Tris buffer and 
800 pM Cu
2+
.  
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Figure 2.4. UV/Vis and fluorescence spectra of vesicles containing PS. (Top) 
Absorbance and (bottom) fluorescence emission spectra are from 100 nm vesicles 
composed of 1 mol % TR-DHPE, 15 mol % DOPS and 84 mol % POPC at 1 mg/mL. 
The experiments were performed in 10mM Tris buffer containing 100 mM NaCl, at pH 
7.4. The red spectra show no addition of CuSO4, while the blue spectra were taken with 
the addition of 100 μM CuSO4. Fluorescence excitation was performed at ~525 nm.  
 
Results at Fixed Total Cu
2+ 
Concentrations 
In the microfluidic experiments discussed above, a continual flow of buffer 
above the SLBs ensured that a constant Cu
2+
 concentration was maintained in the bulk 
solution even as Cu
2+
 bound to the DOPS lipids. In the next set of experiments, 
measurements were performed with bulk vesicle solutions in a cuvette to determine the 
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quenching behavior as the DOPS was titrated with a fixed amount of Cu
2+
 (Figure 2.5). 
In these experiments, the added Cu
2+
 was consumed to form Cu
2+
-DOPS complexes and 
thus the fluorescence response decreased as a function of time before leveling off. The 
data were obtained at multiple CuSO4 concentrations in well mixed solutions.  
CuSO4 solution was added to aqueous solutions containing 100 nm vesicles with 
15 mol % DOPS and 1 mol % TR-DHPE at pH 7.4. The total lipid concentration was 
0.17 mg/ml; hence, the DOPS concentration was approximately 33 μM. Monitoring the 
extent to which the fluorescence was ultimately quenched as a function of CuSO4 
concentration produced a nearly linear rise in the Stern-Volmer plot at lower Cu
2+
 
concentrations before reaching a plateau as the concentration was further increased 
(Figure 2.5). The crossover between these regimes occurred at about 16 µM CuSO4. This 
concentration represented a Cu
2+
 to PS ratio of approximately 1 to 2. In addition to the 
Stern-Volmer data, the Job's method of continuous concentration variation was applied 
to confirm the binding stoichiometry between PS and Cu
2+ 
(Figure 2.6).
81 
Here the total 
molar concentration of PS and Cu
2+ 
was held constant at 33 µM, while their mole 
fractions were varied. The fraction of the quenched fluorescence, which is related to the 
amount of complex formed, was plotted against the mole fraction of Cu
2+
. The inflection 
point of the Job’s plot yielded the binding stoichiometry of the complexes formed. As 
can be seen, the maximum in fluorescence quenching occurs when the mole fraction of 
Cu
2+
 is about 0.33. This is consistent with the Stern-Volmer plot to give a 1:2 binding 
ratio for the Cu
2+
-PS complex. 
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Figure 2.5. A Stern-Volmer plot to determine Cu
2+
-PS binding stoichiometry. A Cu
2+
 
titration experiment was performed for POPC vesicle solutions containing 15 mol % 
DOPS and 1 mol % TR-DHPE. 10 mM Tris buffer containing 100 mM NaCl at pH 7.4 
was used and the indicated amount of CuSO4 was added during vesicle extrusion.  
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Figure 2.6. A Job’s plot showing the binding stoichiometry of the Cu2+-PS complex. 
The experiments were performed in Tris/NaCl buffer (10 mM Tris, 100 mM NaCl, pH 
7.4). Serial 100 nm POPC vesicles containing 1 mol % TR-DHPE, 0 to 15 mol % DOPS 
at 0.17 mg/mL were used and the serial concentrations of CuSO4 ranging from 0 to 33 
µM was added during vesicle extrusion. The total molar concentration of PS and Cu
2+ 
was held constant at 33 µM, while their mole fractions were varied.  
 
 
The formation of a 1:2 Cu
2+
-PS complex is in good agreement with previous 
spectroscopic and titration data with PS lipid and small molecule systems.
59,82,83
  
For example, a 1:2 complex has been shown to be formed between Cu
2+
 and O-phospho-
L-serine and in bulk aqueous solution at basic pH values.
83
 EPR data from that system 
matched the data we got from 15 mol % DOPS in POPC vesicles with a saturation 
concentration of CuSO4.
45
 Analogous CuL2 complexes with amino acids have also been 
reported.
83,84
 As such, the Cu
2+
-PS binding likely involves the amine and carboxylic acid 
groups of two PS molecules and results in the deprotonation of the amine.  
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pH-Driven Reversibility of the Quenching Process 
In a next set of experiments, the reversibility of the 1:2 Cu
2+
-PS complex in 
SLBs was explored as a function of pH in microfluidic channels with continuous buffer 
flow. Figure 2.7A shows the response of four different DOPS concentrations ranging 
from 0 to 20 mol % in POPC bilayers with 0.1 mol % TR-DHPE as the pH was varied in 
buffers that contained 50 nM CuSO4. The fluorescence was initially low after rinsing at 
pH 7.9 for bilayers containing PS. The intensity rose when the pH was reduced to 5.1. It 
could then be raised and lowered reversibly by modulating the pH of the bulk solution. 
The fluorescence intensity of each channel was normalized to its own maximum value to 
facilitate comparisons among the various DOPS concentrations. The quenching was 
highly stable and reproducible. The light exposure was kept sufficiently low such that 
photobleaching was relatively minor in these experiments.  
The fluorescence quenching rate was much slower than the de-quenching process, 
which typically took only a few minutes.  Such results are consistent with the notion that 
the Cu
2+
-DOPS complex formation rate is slow and probably limited by a PS diffusion 
process required for the one ion, two lipid complex to form. On the other hand, when the 
pH was lowered, the complex quickly broke up as the protonation of the negatively 
charged DOPS molecules was rapid. The rate of dequenching upon acidification was 
limited by the rate at which the pH of the buffer solution could be changed within the 
microfluidic device. To further investigate the complex formation process, pH jump 
experiments were performed as a function of CuSO4 concentration (Figure 2.7B). As can 
be seen, the formation rate was significantly attenuated at the lowest Cu
2+
 concentration. 
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Indeed, the quenching took approximately 2 hours to come to completion when only 50 
pM CuSO4 was employed. By contrast, the unquenching reaction was essentially 
independent of Cu
2+
 concentration. Again, the finite time it took to measure 
unquenching was related to the time it took to replace the buffer in the channels. 
 
 
Figure 2.7. The reversible quenching-dequenching process with a varying pH. In (A) the 
fluorescence intensity of 0, 5, 10, and 20 mol % PS is shown as the pH is alternated 
between pH 5.1 (orange background) and 7.9 (blue background) in 1 mM 
citrate/MES/Tris with 50 nM Cu
2+
. (B) Experiments in which different concentrations of 
CuSO4 solution were tested at pH 3.6 (pink background) and 8.0 (blue background) with 
50 pM, 50 nM, and 50 μM levels of CuSO4. The SLBs consisted of 0.1 mol % TR-
DHPE in POPC at the labeled DOPS concentration. The buffer was 1 mM 
citrate/MES/Tris. 
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It should be noted that at 50 μM CuSO4 some quenching was observed even 
when PS was absent (blue data points in Figure 2.7B). This most likely occurred because 
Cu
2+
concentrations in the M range were sufficiently high to result in some direct 
fluorophore-ion interactions without the need for the mediation of the Cu
2+
-DOPS 
complex. Another possible source of fluorophore quenching may be the Cu
2+
-catalyzed 
generation of reactive oxygen species.
85
 This should result in permanent quenching 
independent of pH or Cu
2+
 concentration. Indeed, some permanent quenching was 
observed when the CuSO4 concentration was raised to μM or mM levels, and the degree 
of irreversible quenching was observed to increase with time. However, below 1 μM 
Cu
2+
, only reversible quenching and a very small amount of photobleaching were 
observed. 
 
Metal Ion Specificity for the PS-related Quenching  
In a penultimate set of experiments, we wished to explore the specificity of the 
quenching process to the identity of the cation. Heavy metal ion quenching of 
fluorophores is a common phenomenon,
80
 and thus other divalent cations as well as Ag
+
 
were tested for their ability to bind PS and quench the TR-DHPE fluorophore. The 
results of these experiments are shown in Figure 2.8. 2.4 μM of each metal ion was 
added to solutions of vesicles containing 1 mol % TR-DHPE, 15 mol % DOPS, and 84 
mol % POPC and the resulting quenching was monitored. In all cases, the metal ion was 
added as a chloride salt except Ag
+
, which was added as a nitrate salt. As can be seen, 
Cu
2+
 was the strongest quencher tested, although Ni
2+
 showed some quenching ability. It 
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should be noted; however, that quenching by Ni
2+
 only occurred at ion concentrations as 
high as μM scale compared with Cu2+.  
In additional microfluidic experiments, it was found that when 50 µM Ca
2+
 or 
Cd
2+
 were introduced after 950 pM Cu
2+
, the fluorescence intensity was observed to 
increase slightly, perhaps because these ions were able to displace some Cu
2+
 already 
bound to the PS. Thus, it would appear that an ion has to meet two criteria to induce PS-
mediated quenching. First, the ion has to form a complex with PS, as does Cu
2+
, and to a 
lesser extent Ni
2+
, Cd
2+
 and Ca
2+
. Second, the ion has to quench the fluorophore, as do 
Cu
2+
, Ni
2+
, Sr
2+
, and Co
2+
.
80
 Since only Cu
2+
 and Ni
2+
 fulfill both criteria, they are the 
only two ions tested that generated appreciable PS-mediated quenching. It should be 
noted that Fe
3+
 was also tested, but it was found to only moderately quench TR-DHPE 
regardless of the presence or absence of PS under acidic or basic conditions. This modest 
quenching was presumably due to direct ion-fluorophore interactions (The control 
experiments of direct ion-fluorophore quenching occurring at mM salt concentrations 
can be found in ref.45). 
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Figure 2.8. The quenching of TR-DHPE with various divalent metal chlorides and silver 
nitrate. The experiments were performed at pH 7.4 with 1 mM Tris and 100 mM NaCl. 
2.4 μM of each metal ion was added to solutions of vesicles containing 1 mol % TR-
DHPE, 15 mol % DOPS, and 84 mol % POPC. 
 
Lipid Specificity and Fluorophore Generality  
Finally, to ensure that quenching was specific to PS and general to a wide 
number of fluorophores, various negatively charged lipids and fluorophores were tested 
for pH-dependent quenching (see Table 2.1 for a summary of the fluorophores and lipids 
tested). All PS lipids tested (DLPS, DOPS, and DPPS) quenched lipid conjugated 
fluorophores in the presence of Cu
2+
, but no other lipids tested (PG, PA, PC, GM1, and 
cardiolipin) produced any significant quenching. 
 
 
Co2+ Ba2+ Cd2+ Hg2+ Zn2+ Fe3+ Ca2+ Mg2+ Ni2+ Cu2+Ag+
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Table 2.1. Lipids and fluorophores tested for Cu
2+
 quenching 
 
 
Fluorescence quenching was also monitored in the presence of DOPS and 800 
pM Cu
2+
 for 1 mol % lipid tail group-labeled NBD-PC, tail group-labeled NBD-PS, head 
group-labeled NBD-PS, rhodamine-DHPE, fluorescein-DHPE, bodipy-DHPE as well as 
TR-DHPE concentrations from 0.1 to 5 mol % (complete names of fluorophores and 
lipids provided in “Nomenclature” section). All systems tested showed the similar 
quenching phenomenon. Moreover, the normalized Cu
2+
-PS quenching fraction from 1.0 
mol % TR-DHPE was found to be essentially identical with 0.1 mol %, as was the 
quenching of head group-labeled lipids and tail-labeled lipids. By contrast, fluorophores 
attached to membrane-bound proteins showed no Cu
2+
-PS quenching, presumably 
Lipids Tested Fluorophores Tested 
Quench TR-
DHPE 
Not quench TR-
DHPE 
Quenched by Cu
2+
-PS Not quenched by 
Cu
2+
-PS 
PS (DOPS, 
POPS, DPPS, 
DLPS) 
PG (POPG, DOPG, 
DPPG) 
TR-DHPE 
(ortho- and para-
isomers, mixed or 
separated) Rhodamine labeled 
anti-biotin IgG 
bound to biotin-
conjugated lipids 
PA (DOPA, DSPA) 
PC (POPC) NBD-PC (tail labeled) 
GM1 
NBD-PS (tail or head 
labeled) 
Cardiolipin Rhodamine-DHPE 
  Fluorescein-DHPE  
  Bodipy-DHPE  
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because the fluorophore was too distant from the Cu
2+
-PS complex for quenching to 
occur. Thus, Cu
2+
-PS quenching is highly specific to lipid-conjugated fluorophores 
which presumably have the appropriate in-plane geometry with the Cu
2+
-PS complex to 
afford quenching.  
 
Discussions 
 
The 1:2 Cu
2+
-PS complex observed in this work may have a number of biological 
implications. Given the concentrations of PS (variable, but generally μM to low mM)2 
and Cu
+
/Cu
2+
 (also variable, but ~100 μM is often noted in the literature)66 found in cells, 
it seems reasonable that at least under some conditions Cu
2+
 could exist in 1:2 Cu
2+
-PS 
complexes in vivo. The distribution of both copper and PS in various cell and tissue 
types are often seen to roughly track one another, both being present in relatively high 
concentrations, for example, in human brain tissue.
86,87
 Increased PS thus may serve to 
complex reactive Cu
2+
 in tissues that experience high Cu
2+
 concentrations. This 
complexation ability may be particularly important in mitigating copper poisoning. 
Alternatively, PS may attract Cu
2+
 to tissues that require greater quantities of Cu
2+
, 
although this seems less likely as Cu
+
 should be the dominant species involved in copper 
ion transport.
65
 The 1:2 Cu
2+
-PS complex may also provide insights into observations 
that copper ions and PS both play roles in many biological processes, such as fibril 
formation in neurodegenerative diseases and wound healing.
68,69
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As noted above, PS is known to bind a number of different metal ions. Ca
2+
-PS 
interactions have been the most extensively studied. These interactions are generally 
believed to involve high μM to low mM range equilibrium dissociation constants.58,59,88 
This interaction mediates a number of different protein-PS interactions, specifically the 
membrane binding of C2 domain proteins, annexin proteins, and γ-carboxyglutamic acid 
domain proteins such as prothrombin. Thus, it seems reasonable that the observed 1:2 
Cu
2+
-PS complex might also be involved (interfere or aide) in PS-protein interactions 
even in the presence of trace Cu
2+
 concentrations. 
In addition to other roles, Cu
2+
 may also be involved in oxidation reactions. 
However, the quenching of fluorophores observed in the present experiments was almost 
perfectly reversible as illustrated by Figure 2.7. As oxidation is largely observed at 
relatively high Cu
2+ 
concentrations, it may be possible that at trace Cu
2+
 concentrations, 
1:2 Cu
2+
-PS complexes help mitigate Cu
2+
 mediated oxidation. On the other hand, at 
higher Cu
2+
 concentrations, the complex should become saturated and excess Cu
2+
 may 
mediate oxidation. It should be noted, however, that the high Cu
2+
 concentrations 
required to saturate the 1:2 Cu
2+
-PS complexes are well outside the normal physiological 
range for common healthy cells and tissues. 
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CHAPTER III 
UNQUENCHABLE SURFACE POTENTIAL DRAMATICALLY ENHANCES Cu
2+
 
BINDING TO PHOSPHATIDYLSERINE LIPIDS  
 
Introduction 
 
Ligand-receptor interactions on cell membranes underlie many fundamental 
biological processes such as cell signaling, pathogen recognition and inflammatory 
response.
3,4,41,89
 In multivalent binding systems, a higher surface concentration of 
membrane receptors does not merely provide more sites for interactions, but also can 
increase binding avidity and induce receptor clustering.
41,89,90
 Curiously, however, 
increasing the surface density of receptors typically leads to only modest changes in 
binding avidity.
3,9,41,90
 One example is the bivalent interaction between lipid membrane-
conjugated haptens and antibodies, where KDapp tightens by a factor of only 12 as the 
ligand density is increased sufficiently to switch the binding from predominantly 
monovalent to overwhelmingly bivalent.
90
 In this bivalent binding model, the 
dissociation constant for the overall process KDapp changes with the varying membrane 
receptor density [R]s which has a unit of mol/m
2 
(Eq. 3.1).
90
 The individual dissociation 
constant KD1 and KD2 for this two-step binding model are interpreted by Eqns. 3.2 & 3.3, 
where [B] represents the concentration of bivalent ligands at equilibrium.
90
  
      
      
          
                                                       (3.1) 
    
       
     
                                                            (3.2) 
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                                                          (3.3) 
The change of KDapp with [R]s can be fitted to a hyperbolic function to abstract the KD1 
and KD2 values. When [R]s is increased by 20-fold from [R]s to 20[R]s, the ratio of new 
KD’ over the old KD can be representated as {KD2 + 2[R]s}/ {KD2 + 40[R]s}. If KD2 >> 
[R]s, the ratio equals 1 which shows almost no change in the binding affinity. If KD2 << 
[R]s, the ratio equals 1/20. Therefore, the 20-fold increase of membrane receptor density 
can only cause no more than 20-fold change of binding affinity. Increasing the 
interfacial charge by tuning the pH of the bulk solution can also enhance the binding of 
negatively charged antibodies to membranes.
91
 This, however, also leads to only about 
an order of magnitude tightening in the KDapp value as the positive charge on the surface 
is rapidly attenuated as the protein molecules become attached. In fact, most effects of 
ligand density, ligand presentation or modulations of the surface charge lead to only 
modest effects on the apparent dissociation constant.
41,92-94
  
When it comes to the binding of charged ligands to charged receptors, the surface 
charges also vary with the receptor densities. The concentration of the ligands in the 
double layer of the membrane surface could be lower or higher than the bulk 
concentration when the ligands are coulombically repelled or attracted to the surface.
95
 
The Coulombic effects might cause the binding affinity of charged ligands and surface 
receptors to change much more drastically than predicted by the previously-established 
bivalent binding model. This phenomenon should be especially evident for the ligands 
that bind to the membrane receptors without attenuating the surface charges. 
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Herein, we demonstrate that the dissociation constant between Cu
2+
 and PS lipid 
is highly sensitive to PS density in the membrane. Strikingly, the apparent KDapp value of 
Cu
2+ 
for PS in SLBs tightens by a factor of 17,000 when the PS density is increased from 
1.0 mol % to 20 mol %. This change is significantly larger than what would be expected 
for changing for largely monovalent to predominantly bivalent binding.
9,90
 Rather, this 
dramatic increase in affinity is largely caused by the increased charge on the membrane, 
which leads to an increase in Cu
2+
 in the double layer (Figure 3.1). Significantly, the 
binding of Cu
2+
 to PS lipids causes little if any attenuation in the surface potential, 
unlike the binding of other divalent metal ions such as Ca
2+
 and Mg
2+
.
25,28
 This is a result 
of the deprotonation of the two PS lipids upon Cu
2+
 binding (Figure 3.1). These results 
may have implications for Cu
2+
-PS interactions in cellular membranes, where the PS 
concentration on the outer leaflet of the plasma membrane increases dramatically upon 
apoptosis. Noted that in this chapter, monovalently bound complex will be referred to as 
Cu(PS) and bivalently bound complex is referred to as Cu(PS)2 while Cu
2+
-PS represents 
the metal-lipid complexes in general.  
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Figure 3.1. Schematic representation of the change of KDapp with PS density on SLBs 
(top) and the binding reaction equation (bottom). The binding of Cu
2+
 to 2 PS lipids 
causes the release of 2 protons leaving the net surface charge unchanged. 
 
Experimental Section 
 
Materials 
1-Palmitoyl-2-oleoyl-sn-glyero-3-phosphocholine (POPC), 1-palmitoyl-2-oleoyl-
sn-glycero-3-phospho-L-serine (POPS), 1,2-dioleoyl-sn-glycero-3-phospho-L-serine 
(DOPS) and 1,2-dipalmitoyl-sn-glycero-3-phospho-L-serine (DPPS) were purchased 
from Avanti Polar Lipids (Alabaster, AL). The fluorescent sensor used in this paper, 
Texas Red 1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine (TR-DHPE) was 
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purchased from Invitrogen (Eugene, OR). The vesicles were prepared and stored in 10 
mM tris(hydroxymethyl)aminomethane (Tris) buffer containing 100 mM NaCl. The pH 
of the Tris/NaCl buffer was set to 7.4 by dropwise addition of 1.0 M HCl. The chemicals 
used such as  Tris, NaCl, HCl, CuCl2, ethylenediaminetetraacetic acid (EDTA) and 
nitrilotriacetic acid trisodium salt (NTA) were purchased from Sigma-Aldrich (St. Louis, 
MO). Most of these chemicals have ≥ 99.999% purity while NTA has ≥ 98% purity. 
Purified water (18.2 MΩ•cm) for the experiments was acquired from a NANOpure 
Ultrapure Water System (Barnstead, Dubuque, IA). Borosilicate glass coverslips (24 × 
40 mm, No. 1.5, Corning Inc.) were used as planar solid supports for SLBs. PDMS 
(polydimethylsiloxane, Dow Corning Sylgard Silicone Elastomer-184) was purchased 
from Krayden, Inc (El Paso, TX). 
 
Vesicle Preparation, Microfluidic Device Fabrication and Bilayer Formation 
The experiment methods for preparing small unilamellar vesicles (SUVs), 
fabricating microfluidic devices and forming lipid bilayers in the devices were all 
described in Chapter II. 
 
Binding Measurements through Fluorescence Microscopy  
Binding measurements with SLBs containing different PS concentrations were 
performed inside the microfluidic devices described above. The experimental set-up 
scheme is shown in Figure 1.2. First, SLBs with a specific PS mol % were made in 6 or 
7 parallel microfluidic channels. 10 mM Tris buffer (pH 7.4) containing 400 μM EDTA 
36 
was introduced into each channel to remove any possible heavy metal ion contaminates. 
Then Tris buffer containing different Cu
2+
 concentrations was flown through individual
channels of the PDMS/glass microfluidic device through each inlet port using 0.6 mm 
internal diameter Teflon tubing (SPC Technology). Flow through the device was gravity 
driven with an average flow rate of ~100 μL/h in each microfluidic channel. The 
consumed buffer drained from each outlet port to a waste container. Buffer was 
constantly flowed through the channels during all experiments. The fluorescence of each 
channel was monitored by an inverted epifluorescence Nikon Eclipse TE2000-U 
microscope until equilibrium was reached. When low Cu
2+
 concentrations were
employed (less than nM scale), several hours were required for equilibrium to be 
established. The fluorescent images of the channels were captured by a MicroMax 1024 
CCD camera (Princeton Instruments), collected using MetaMorph software (Universal 
Imaging) and then processed with Origin 7.5 software (OriginLab Corporation). For 
competitive binding method experiments, 1 or 10 μM NTA was introduced into the 
channel accompanied by 10 mM Tris buffer containing different Cu
2+
 concentrations
while the rest of the experiment set-up and the data processing remained the same. 
Vibrational Sum-Frequency Spectroscopy (VSFS) Characterization of the Cu
2+
-PS
Complex
VSFS is a surface-specific non-linear optical technique.
46,47
 In our setup, a fixed
wavelength visible (516 nm) laser beam and a tunable wavelength IR laser beam are 
spatially overlapped on lipid/water interfaces. Photons from the two laser beams mix at 
37 
the interface to form a sum frequency beam. The intensity of this sum frequency beam is 
proportional to the intensity of the visible and IR laser beams and the square of the 
second-order non-linear susceptibility.
46,47
 As the second order non-linear susceptibility
is non-zero only in media that lack inversion symmetry, VSFS is inherently surface 
specific. The intensity of the sum frequency beam is increased when the IR beam is 
resonant with molecular vibrations at the lipid/water interface. To generate a vibrational 
spectrum of the lipid/water interface, the intensity of the sum frequency beam can be 
monitored with a changing IR beam frequency. 
The VSFS experimental setup (purchased from EKSPLA, Lithuania) consisted of 
a 1064 nm Nd:YAG laser (pulse duration: 30  ps; pulse energy: 40 mJ; maximum 
repetition rate 50 Hz), which was directed to the harmonic unit (H500).  The second 
harmonic (532 nm) and fundamental beams from the harmonic unit pump the optical 
parametric generator/ difference frequency generator (PG501/DFG) unit. The infrared 
frequency can be tuned between 1000 cm
-1
 and 4000 cm
-1
 and the spectral resolution is <
6 cm
-1
. For VSFS experiments at the air/water interface, a PTFE Langmuir trough
(NIMA technology, England) equipped with pressure sensor and controllable barriers 
was used. The trough had an area of 65 cm
2
 and subphase volume of 35 mL. A
Langmuir monolayer of lipid molecules was formed at the air/water interface and the 
VSFS spectra were collected in the absence and presence of metal ions in the subphase. 
The IR and visible beams were spatially and temporally overlapped at air/water interface 
and the sum frequency signal was collected at an angle of 59˚. The incident angles of the 
IR and Visble beams on to the monolayer/water interface were of 55˚ and 60˚ 
38 
respectively. The energy of visible beam at the sample stage was 400 μJ and the infrared 
beam was 150 μJ at 2875 cm-1. The VSFS signal was collected at 3 cm-1 intervals and
each point on the spectrum is an average of 150 laser pulses. The intensity of the 
collected VSFS signal was normalized to the corresponding IR and visible intensities. 
VSFS spectra of the air/water interface were obtained on lipid monolayers 
composed of 100 mol % DPPS. 100 mM Tris buffer at pH 7.4 was used in the subphase 
for all experiments. The Tris buffer containing 100 μM CuCl2 or 100 μM CaCl2 were 
used as subphase solution to compare with the buffer without divalent metal ions. The 
monolayers were studied at a surface pressure of 17 mN/m at 21˚C. 
Surface Potential Measurements by Kelvin Probe 
Surface potential measurements on DPPS monolayers with 100 μM CuCl2 or 100 
μM CaCl2 in the subphase were made in a Langmuir trough (KSV 5000, KSV 
Instruments, Ltd., Helsinki, Finland). This trough was equipped with a Kelvin probe for 
performing vibrating capacitor measurements.
96,97
 Similar to the VSFS experiments, a
Langmuir monolayer of DPPS molecules was formed at the air/water interface and 100 
mM Tris buffer at pH 7.4 was used in the subphase for all experiments. Tris buffer 
containing 100 μM CuCl2 or 100 μM CaCl2 were used as subphase solution to compare 
with the buffer without divalent metal ions. Each measurement was carried out after 
waiting 20 min to stabilize the reading from the Kelvin probe. The surface potential 
values were determined from the average of 4 measurements. 
39 
Electrospray Ionization Mass Spectrometry (ESI-MS) Characterization of the Cu
2+
-PS
Complex 
The ESI-MS spectra were acquired on a Waters Synapt HDMS G2 mass 
spectrometer (Waters UK Ltd., Manchester, U.K.). Negatively charged ions were formed 
by nano-ESI using a source temperature of ∼80°C and a capillary voltage of -1.8−2.0 kV. 
The sampling cone voltage was set at 25 kV and the extraction cone voltage was 2.0 kV. 
The SUVs containing 80 mol % POPC and 20 mol % POPS were firstly prepared in 1 
mM concentration in 10 mM ammonium acetate buffer (pH 7.4) and then diluted by 100 
times in H2O for ESI-MS experiments. 
Results 
Cu
2+
-PS Fluorescence Quenching Assay
The fluorescence quenching assay used for binding measurements was applied 
inside the microfluidic devices.
45
 To measure the Cu
2+ 
binding affinity at different PS
concentrations, various vesicle solutions containing 0 to 20 mol % POPS, 1.0 mol % TR-
DHPE and POPC were incubated inside microfluidic devices to form SLBs. The SLBs 
containing 0.5 mol % TR-DHPE were also tested, which gave similar binding results. 
Besides POPS, other PS lipids with different acyl chains such as DPPS and DOPS in 
POPC SLBs were also tested and they showed similar binding affinity with copper ions. 
Buffer solutions containing different Cu
2+
 concentrations were introduced into each
channel and flowed continuously until the fluorescence signal stabilized. At sub-nM 
40 
concentration of Cu
2+
, it took several hours for equilibrium to be established. Figure 3.2
shows fluorescence images and the corresponding line scans of SLBs containing 0, 5.0, 
10, 15 and 20 mol % POPS without (left) and with (right) 10 nM CuCl2. As can be seen, 
the fluorescence response of each channel was essentially identical in the absence of 
Cu
2+
. Upon introducing 10 nM CuCl2 to the solution, the fluorescence of TR-DHPE was
quenched to a greater degree at higher PS concentrations. Moreover, no quenching was 
observed without POPS in the bilayer. Such quenching has been attributed to the 
formation of complex between Cu
2+
 and PS, which can, in turn, quench a wide variety of
fluorophores.
45
 Such quenching is employed below to quantitatively investigate the
interaction between Cu
2+
 and PS on lipid bilayer surface.
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Figure 3.2. (A) Fluorescence images and (B) line scans from lipid bilayers in a multi-
channel microfluidic device. The POPC SLBs contain 0 to 20 mol % POPS along with 
1.0 mol % TR-DHPE. The fluorescence is shown in the absence of CuCl2 (left panel in 
A and red line scan in B) and in the presence of 10 nM CuCl2 (right panel in A and blue 
line scan in B) at pH 7.4 with 10 mM Tris buffer. The fluorescence line scans in B are 
taken from the regions along the dotted red lines shown in A. 
 
 
Non-competitive Binding Measurement 
In the next set of experiments, the multi-channel microfluidic devices containing 
SLBs were used to measure binding isotherms for Cu
2+
 to PS for membranes containing 
1.0~7.5 mol % POPS (Figure 3.3). The maximum fraction of fluorophores that were 
B
0
5000
10000
15000
20000
25000
30000
35000
40000
0 300 600 900 1200 1500 1800
Fl
u
o
re
sc
e
n
ce
 In
te
n
si
ty
Position (μm)
3143 3275
No Cu2+ added 10 nM Cu2+ added 
20    15    10    5.0    0
A 0 nM Cu2+ 10 nM Cu2+
PS mol % 20    15    10    5.0    0
 
 
42 
 
quenched increased with an increasing POPS concentration. This is expected as the 
average distance between Cu
2+
-PS complexes and fluorophores becomes shorter at 
higher complex concentration and, therefore, the quenching becomes more efficient.
98
 
More significantly, these curves reveal a tighter binding between Cu
2+
 and PS with 
increasing concentrations of POPS. The data were fit to Langmuir isotherms using 
Eq.3.4 in order to abstract an apparent equilibrium dissociation constant, KDapp:
90,99,100
  
           
      
              
      (3.4) 
In this case, ΔF is the fraction of lipid-bound dye molecules that are quenched by the 
Cu
2+
-PS complex at each Cu
2+
 concentration, while ΔFmax represents the maximum 
fraction quenched at the saturation concentration. [Cu
2+
] represents the free Cu
2+
 
concentration in the bulk solution when equilibrium is established. It should be noted 
that buffer containing CuCl2 is continuously flowed over the SLBs throughout the 
experiment so the bulk Cu
2+
 concentration will not be depleted once equilibrium is 
established. Moreover, equilibrium is determined to have been reached when the 
fluorescence response from the membrane stops changing as a function of time as the 
buffer is continuously flowing. The values of KDapp determined at each POPS 
concentration in Figure 3 are listed in the “KDapp (M, non-competitive)” column in Table 
3.1.  
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Figure 3.3. Non-competitive binding curves of SLBs containing 1.0 to 7.5 mol % PS. 
The quenching response of SLBs composed of 1.0 mol % TR-DHPE in POPC with 1.0 
to 7.5 mol % POPS were plotted as a function of Cu
2+
 concentration. The fluorescence 
intensities with different Cu
2+
 concentrations at pH 7.4 were normalized to the 
fluorescence response without Cu
2+ 
at the same pH where 400 μM EDTA was added into 
the system to chelate the metal ions. The fraction of fluorescent dye that was quenched 
(one minus the normalized fluorescence intensity) was plotted here as a function of Cu
2+
 
concentration along with a solid line fit of the data using Eq. 3.4. 
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Table 3.1. Binding Constants of non-competitive binding curves for 1.0 to 7.5 mol % PS 
and competitive binding curves for 7.5 to 20 mol % PS  
PS mol % in 
SLBs 
K
Dapp
 (M, 
non-
competitive) 
K
Dapp
 (M, 
competitive) 
KDcom (M) 
1.0 1.1 x 10
-7
 - - 
3.0 1.5 x 10
-8
 - - 
5.0 2.7 x 10
-9
 - - 
7.5 1.8 x 10
-10
 5.1 x 10
-11
 5.1 x 10
-6
 
10 - 1.6 x 10
-11
 1.6 x 10
-6
 
15 - 9.7 x 10
-12
 9.7 x 10
-7
 
20 - 6.4 x 10
-12
 6.4 x 10
-7
 
 
 
Competitive Binding Measurements 
Binding curves could not be established for SLBs containing more than 7.5 mol% 
POPS because the value of KDapp continued to tighten and quenching measurements 
needed to be made with ever lower concentrations of CuCl2 in the buffer. This was 
problematic because trace Cu
2+
 contamination in the buffer began to affect the results as 
the KDapp value continued to tighten. Therefore we switched to a competitive binding 
method to obtain KDapp values from SLBs containing 7.5 to 20 mol % POPS (Figure 3.4). 
Such methods are routinely applied to measuring the binding affinity of transition metal 
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ions to proteins and peptides when the binding constant is below nM.
101-103
 Herein, 10 
M of a metal ion chelator, nitrilotriacetic acid (NTA), was used to shift the binding 
curves into the M range where the background Cu2+ contamination was 
negligible.
102,104
  
Figure 3.4. Competitive binding curves of SLBs containing 7.5 to 20 mol % PS. The 
quenching response of SLBs containing 1.0 mol % TR-DHPE, 7.5 to 20 mol % POPS in 
POPC with 10 μM NTA. The quenched fraction was normalized to the fluorescence 
response without Cu
2+ at the same pH (pH=7.4) where 400 μM EDTA was added to the 
system. The solid lines represent least square fits of the data using Eq. 3.5. Moreover, 
buffers containing 1 μM NTA were also tested to confirm the KDapp values and gave 
similar results. 
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as a linear axis to show the quenching response within μM Cu2+. In these competitive 
binding measurements, the original Langmuir isotherm binding model (Eq. 3.4) needs to 
be modified based on the actual “available” Cu2+ concentrations. In NTA-Cu2+ 
binding                              
   , the equilibrium dissociation constant for 
this binding: 
   
                
   
        
                                                 (3.5) 
Therefore, with NTA
3-
 in solutions, it can be regarded as a “Cu2+ buffer” and the 
“available” free Cu2+ concentration for PS can be represented as:  
              
        
  
        
                                                (3.6) 
As we generally used relatively high Cu
2+
 concentration in this competitive binding 
method (sub-μM to 10 μM scale), the background contaminate Cu2+ concentration 
(around sub-nM) in buffer can be ignored, thus total Cu
2+
 concentration: 
                           
                                       (3.7) 
Since total Cu
2+
 concentration can be represented as:                          
         
(3.8) 
Combining Eq. 3.6 and Eq. 3.8 gives: 
            
      
  
       
  
                                               (3.9) 
which is the available Cu
2+
 concentration in the buffer when NTA
3-
 exists. The quenched 
fraction of fluorescence intensity is correlated with the binding between Cu
2+
 and PS and 
follows Langmuir binding model (Eq. 3.4).
99,100
 Thus the quenched fraction can be 
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related to the equilibrium dissociation constant (KDapp) for the Cu
2+
-PS complex by Eq. 
3.10:                                                    
               
  
     
 
           
                 
                                        (3.10) 
where ΔF is the fraction of TR-DHPE quenched by Cu2+-PS complex, while ΔFmax 
represents the maximum fraction which can be quenched and [Cu
2+
]avail is the 
equilibrium (unbound) Cu
2+
 concentration when equilibrium is established. Since we 
continuously flow buffer containing Cu
2+
 into the system, the added “available” Cu2+ 
concentrations represent the equilibrium Cu
2+
 concentrations. Applying Eq. 3.9 into Eq. 
3.10 gives: 
                
  
     
 
      
               
       
  
 
                                  (3.11) 
Now we can see that the apparent dissociation constant with the competitor, KDcom, 
which is extracted from the competitive binding curve when NTA
3-
 is present, can be 
represented as:  
                         
       
  
                                      (3.12) 
                                                         
     
  
       
  
                                                (3.13) 
The protonation of NTA should be also considered to make correction of the pH-
dependent NTA-Cu
2+
 binding constant KL. Since 
                                
                           
                                     (3.14) 
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where βH,n is defined as the accumulated protonation constant of HnNTA where KH,n is 
the n-th protonation constant. The corrected NTA-Cu
2+
 binding constant KL
 
can be 
represented as: 
                      
         
          
                   (3.15) 
where KNTA is the absolute affinity of NTA
3-
  for binding Cu
2+
, which is 10
-13.1
M 
according to the ref.
105,106
 When pH=7.4, we can calculate KL
 
at this pH based on KNTA 
and KH,n from the reference (KH,1 = 10
10.3
M, KH,2 = 10
2.9
 M, KH,3 = 10
1.7
 M) 
106,107
, which 
gives KL ≈10
-10 
M. 
Now based on Eq. 3.13 and the NTA-Cu
2+
 binding constant, we can deduce the 
intrinsic dissociation constant KDapp of Cu
2+
-PS binding. The quenching curves were fit 
to a modified Langmuir isotherm binding model (Figure 3.4) based on the actual 
“available” Cu2+ concentrations (Eq. 3.16) then KDapp can be calculated by Eq. 3.13:  
          
      
            
                                       (3.16) 
Using these equations, the KDapp values for 7.5~20 mol % PS were calculated and listed 
in “KDapp (M, competitive)” column in Table 3.1 along with the KDcom values in each 
condition.  
To confirm that the competitive binding experiments provided accurate KDapp 
values, the KDcom value for a membrane containing 7.5 mol % PS was also measured. In 
this case, the calculated KDapp value from competitive binding was 5.1 x 10
-11 
M, which 
differs by a factor of less than three from non-competitive binding measurements. One 
might have wished to use the competitive method to compare dissociation constants with 
even lower concentrations of POPS. However, KDcom values under those circumstances 
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were larger than 10 μM. Of course, adding more than 10 µM Cu2+ exceeds the metal-
buffering capacity of the 10 M NTA solution. Therefore, the NTA-based competitive 
binding method was only used for the range of POPS concentration from 7.5 to 20 
mol %. 
 
Characterization of the Negatively-charged Cu
2+
-PS Complex 
The data in Figures 3.3 and 3.4 are fits to isotherms that assume non-cooperative 
binding. This assumption is unusual for cation binding at an interface. Indeed, cation 
binding would normally be expected to anti-cooperative because earlier binding events 
would normally make subsequent ones less favorable due to increasing electrostatic 
repulsion. For example, Ca
2+
 and Mg
2+
 bind with phosphate and carboxyl groups on 
PS
26,108,109
 and this attenuates the negative charge on the bilayer.
25,30
 This is not expected 
to be the case, however, for Cu
2+
-PS binding where 2 protons should be released for 
every Cu
2+
 that binds bivalently to phosphatidylserine (Figure 3.1). To verify this 
difference, we performed several experiments to test the change in interfacial potential 
upon Cu
2+
 and Ca
2+
 binding. 
First, vibrational sum frequency spectroscopy (VSFS) was used to measure the 
change in interfacial water structure
46-48
 upon the introduction of 100 M CuCl2 and 100 
M CaCl2 to the aqueous subphase below a Langmuir monolayer of DPPS lipids (Figure 
3.5). The sharper peaks at 2880 and 2950 cm
-1
 are CH stretch modes from the lipid acyl 
chains,
48,96
 while the broader peaks at 3200 cm
-1
 and 3400 cm
-1
 arise from the alignment 
of interfacial water below the monolayer.
110
 The oscillator strength in the OH stretch 
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region has been shown to vary strongly with changes in the interfacial potential of 
monolayers composed of lipids, surfactants or macromolecules.
46,48,111
 Specifically, 
highly charged surfaces order more water molecules, resulting in a larger OH stretch 
oscillator strength.
46
 In fact, the relatively large peak intensities in the OH stretch region 
in the absence of added divalent metal cations comes from the negative charge on the 
lipids (black plot in Figure 5). This peak is expected to be attenuated by the addition of 
metal cations if the interface potential is reduced. Indeed the oscillator strength of the 
3200 cm
-1
 resonance decreased 48% upon the introduction of Ca
2+
 (blue plot in Figure 5). 
However, the addition of 100 µM Cu
2+
 only causes a reduction of 7% in the oscillator 
strength in the OH stretch region (red plot in Figure 5). The greater reduction in water 
structure upon introduction of Ca
2+
 is consistent with the greater attenuation of the 
negative charge.
112
 By contrast, the more modest change upon the addition of Cu
2+
 
supports the idea that the surface charge is less perturbed upon Cu
2+
 binding. It should 
be noted that some attenuation in the 3200 cm
-1
 resonance is expected with 100 µM Cu
2+
 
because this concentration is fairly high enough to lead to some Cu
2+
 binding with the 
phosphate. Also, the 3400 cm
-1
 resonance was perturbed by both Ca
2+
 and Cu
2+
 as this 
resonance reflects the water molecules directly bound to the lipid headgroup.
113
 
The surface potential of the DPPS monolayer was also measured directly using a 
Kelvin probe.
96,97
 Adding 100 µM Ca
2+
 caused the surface potential to raise 116 ± 3.5 
mV, whereas adding 100 µM Cu
2+
 only caused an increase of 42 ± 2.8 mV. As such, the 
change in the surface potential upon the addition of Ca
2+
 was almost three times greater 
for Cu
2+
. Given that the binding affinity for Cu
2+
 to PS is much tighter than Ca
2+
 while 
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the measured potential change is considerably smaller, the result is again consistent with 
only a small change in surface charges as Cu
2+
 is added.  
Figure 3.5. VSFS spectra of DPPS monolayers with divalent metal ions. 100 μM CuCl2 
(red data points) and 100 M CaCl2 (blue data points) were introduced in the subphase. 
The figure also contains a plot with 10 mM Tris buffer, but without any divalent metal 
salts for comparison (black data points). All measurements were made at pH 7.4 with a 
surface pressure of 17 mN/m at 21  C. The spectra were fitted to a Voigt profile to obtain 
the peak frequency, width and oscillator strength of each vibrational band.  
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Electrospray mass spectrometry (ESI-MS) was utilized as a final method to 
confirm the Cu
2+
 binding model. The results revealed dominant m/z peaks corresponding 
to Cu
2+
-PS binding complex consisting of one metal ion and two lipids with a net charge 
of -2 (Figure 3.6, m/z=791.2). This is again consistent with the idea that the PS lipids are 
deprotonated upon Cu
2+
 binding.   
 
Figure 3.6. The negative mode ESI-MS spectra of PS-contained vesicles without or with 
Cu
2+
. The vesicles are 10 μM 80 mol % POPC /20 mol % POPS (A) with 2 μM EDTA 
or (B) with 2 μM CuCl2. The m/z peaks at 760.7 correspond to POPS with 1 negative 
charge while the peak series around 791.2 represent [2POPS-2H+Cu]
2- 
ions which carry 
2 negative charges. 
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Discussions 
 
The Change of Cu
2+
-PS
 
Binding Affinity with PS Density 
As demonstrated above, the affinity of Cu
2+
 for SLBs containing 1.0 to 20 mol % 
PS increases by a factor of 17,000. This apparent enhancement in affinity is 
predominantly due to the increase in surface charge with a small contribution from 
bivalent binding at higher POPS concentrations. First, because the surface charge 
increases 20 fold from 1.0 to 20 mol% POPS, the concentration of Cu
2+
 in the double 
layer goes up substantially. This can be quantified using the Grahame equation (Eq. 
3.17).
95
 
       sinh  
  
    
            CuCl         
   
    
   
   
                (3.17) 
where σ is the surface charge density (C/m2), ψ0 is the surface potential (mV) and [Tris
+
] 
and [CuCl2] are the concentrations of protonated Tris and CuCl2 in the buffer (M). [Tris
+
] 
was calculated by the Henderson-Hasselbalch equation
114
 using a pKa of 8.0,
115
 a pH of 
7.4 and a total Tris concentration of 10 mM, which gives a [Tris
+
] equal to 8 mM. 
[CuCl2] used in Eq. 3.17 was equivalent to the measured KDapp value for each SLBs 
containing PS. The derivation of Eq. 3.17 can be found in reference 95. It should be 
noted that this form of the Grahame equation assumes that the counter ion for [Tris
+
] is 
Cl
-
 as the pH of the Tris buffer was adjusted using HCl. The equation also ignores the 
addition of NTA used for the competitive binding curves. As the NTA concentration is 
three orders of magnitude lower than [Tris
+
], this simplification should not affect the 
output of the equation. The surface charge density σ was determined using Eq. 3.18,  
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 e
 
                                      (3.18) 
where the lipid headgroup area S was taken to be 70 Å
2
.
116
 Here e is the fundamental 
unit of charge and χPS and χTR represent the mole fractions of PS and TR-DHPE in the 
SLBs while the PS and TR-DHPE lipid each possess one negative charge. Note that this 
calculation does not take into account the surface charge of the glass. This assumption is 
reasonable as it has been shown that the supported bilayers will shield the objects in 
solution above the bilayer from being affected by the surface charge of the glass, even at 
the modest salt concentrations used in these experiments.
117-119
 The calculated σ values 
from Eq. 3.18 were plugged in Eq. 3.17 to solve for ψ0 by MATLAB. Using the surface 
potential ψ0 together with the KDapp values measured in Figures 3.3 & 3.4, it is possible 
to calculate the intrinsic dissociation constant, KDint, which takes into account the 
adjustment for charge (Eq. 3.19),
30,95
 
                 
     
  
                                    (3.19) 
The calculated KDint values are listed in Table 3.2 and are plotted as a function of POPS 
density in Figure 3.7B.  
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Table 3.2. The calculated σ, ψ0 and surface charge-adjusted dissociation constants KDint 
for Cu
2+ 
binding of SLBs containing 1.0~20 mol % PS 
 
 
 
 
 
 
The results show that the surface charge on the bilayer has a dramatic effect on 
KDapp for Cu
2+
-PS binding, while KDint only varies slightly with the mol % of POPS in 
the membrane. The remaining one order of magnitude change in KDint arises from the 
shift from monovalent to divalent binding at higher mol % POPS. Similar to the bivalent 
binding model described in “Introduction” by Eqns.3.1 to 3.3, Cu2+-PS binding also 
consists of two sequential steps which have individual dissociation constants KD1 and 
KD2, respectively. The measured KDapp and KDint values were both fit as a function of PS 
surface density to Eq. 3.1 (Figure 3.7). Figure 3.7A shows that the changing KDapp with 
increasing PS surface density cannot fit to Eq. 3.1 while in Figure 3.7B, the change of 
KDint with PS surface density fits well to Eq. 3.1, yielding a KD1 of 1.8 μM and a KD2 of 
0.026 μmoles/m2. 
PS mol % σ (C/m2) Ψ0 (mV) KDint (M) 
1.0 -4.6 x 10
-3
 -22 6.1 x 10
-7
 
3.0 -9.1 x 10
-3
 -40 3.4 x 10
-7
 
5.0 -1.4 x 10
-2
 -56 2.1 x 10
-7
 
7.5 -1.9 x 10
-2
 -71 4.5 x 10
-8
 
10 -2.5 x 10
-2
 -83 1.0 x 10
-8
 
15 -3.7 x 10
-2
 -101 2.5 x 10
-8
 
20 -4.8 x 10
-2
 -115 4.9 x 10
-8
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Figure 3.7. KDapp and KDint values plotted as a function of PS surface density. The data 
points (black dots) are plotted as PS surface density in units of μmoles/m2 (top x-axis) 
and PS mol % (bottom x-axis). The red line in each panel is a fit of Eq. 1 to the data. To 
clearly present the data points, the y-axis in (A) is plotted as a logarithmic scale while 
the y-axis in (B) is linear. 
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As noted above, the lack of change in surface charge with Cu
2+
 binding to PS is 
dramatically different from the binding of other divalent cations such as Ca
2+
 and 
Mg
2+
.
25,28,30
 In other words, the accumulation of Cu
2+
 in double layer of the negatively-
charged surface should take main responsibility for the tightening in KDapp with PS 
concentration as it causes nearly four orders of magnitude change in apparent binding 
affinity while the monovalent-to-bivalent binding only contributes one order of 
magnitude change. 
 
Physiological Implications of Cu
2+
-PS Binding  
As the third most abundant transition metal in human body, copper is necessary 
for the activity of various proteins and is tightly regulated by chaperons and enzymes in 
healthy cells.
32,33
 In healthy tissues, the total copper concentration is generally around 
0.1 mM.
32
 Moreover, there is little uncomplexed copper (~10
-18 
M) in the cytoplasm.
66
 
This can change in diseased tissue. Previous report concerning the “free” copper 
concentration in the cytoplasm are mainly based on studies in bacteria and yeast.
66
 It has 
been argued that the situation in higher organisms with specialized tissues, such as 
human neuron systems, might be different, especially under specific pathological 
conditions.
32
 For example, it has been found that a build-up of labile Cu
2+
 is probably 
toxic to cells and closely linked to neurodegenerative disorders such as Wilson’s disease 
and Alzheimer’s disease.33,34  
Various approaches have been employed to study Cu
2+
-protein interactions and 
Cu
2+
 is generally found to bind negatively charged moieties on proteins as well as the 
 
 
58 
 
lone electron pairs of nitrogen on histidine, lysine, arginine and N-terminus.
35-38
 There 
has been little discussion as to how Cu
2+
 interacts with lipids or the possibility of lipid 
membranes serving as metal ion reservoirs when homeostasis breaks down. As one of 
the most abundant negatively charged phospholipids in human membranes, PS lipids 
play important roles in cell apoptosis, blood clotting and embryonic development.
2,20-23
 
The interactions between Cu
2+
 and PS have numerous biological implications, such as 
the PS-dependent protein-membrane binding and the oxidative damage of cell 
membranes.
2,39
 The consequences of these interactions are probably more pronounced 
when PS lipids are flipped from the inner to outer leaflets of plasma membranes during 
cell apoptosis or other biological events, which increase the exposed PS density on cell 
surfaces and bring PS into direct contact with a Cu
2+
-rich environment.
24,40
 With a 
relatively high negatively-charged PS density on the cell surface, the apparent binding 
affinity to Cu
2+ 
are likely to be enhanced, which might entitle PS to be a candidate for 
copper ion reservoir.  
Additionally, the intriguing results shown in this paper also inspire us to consider 
the possibility of PS co-binding multiple divalent metal ions such as Cu
2+
 and 
Ca
2+
/Mg
2+
,
26
 as well as the co-binding for PS-related proteins.
2,120,121
 Since Cu
2+
-PS 
complexes still possess negative charges to attract other metal ions and proteins, it is 
appealing to investigate if these Cu
2+
-PS interactions can affect or disrupt the PS binding 
of other molecules under physiological conditions. 
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CHAPTER IV 
BETA AMYLOID-METAL ION-MEMBRANE INTERACTIONS UNDER COPPER-
DEFICIENT PATHOLOGICAL CONDITIONS 
 
Introduction 
 
Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by 
memory loss, cognitive decline and physical deterioration.
33,122
 It is typically marked by 
the extracellular accumulation of amyloid β-peptides (Aβ) and neuron cell death. Aβ is a 
peptide of 40~42 amino acids which derives from the proteolytic cleavage of the 
transmembrane amyloid precursor protein (APP).
122
 Aβ monomers tend to self-assemble 
into neurotoxic soluble oligomers or even fibril aggregates through their hydrophobic 
domains while various approaches have been employed to indicate that this pathologic 
deposition process is promoted by transition metal ions such as Cu
2+
 and Zn
2+
.
123-126
 
Interestingly, total Cu
2+
 concentration is generally reported to decrease in AD brain 
tissues, probably because Cu
2+
 is abnormally redistributed, leaving the cells deficient in 
copper.
127-129
 However the Cu
2+
 level in lipid rafts is adversely associated with total Cu
2+
 
concentration as people found that copper are concentrated (μM ~ mM) in lipid rafts.128 
Concurrently in these AD tissues, Aβ localize on lipid rafts in neural membranes 
whereas a large quantity of aggregated Aβ are observed to associate with negatively-
charged lipids such as phosphatidylserine (PS).
130-135
 Under these conditions, Aβ-Cu2+ 
deposits on cell surface can aggravate cell death by causing lipid oxidation damage due 
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to the redox activity of copper. Despite a general understanding of these events, several 
fundamental questions with regard to the underlying mechanisms remained to be 
answered. Where can Aβ obtain Cu2+ in these copper-deficient AD tissues? Do specific 
negatively-charged lipids actually serve as metal ion reservoirs for Aβ to oligomerize? Is 
the attachment of Aβ to the cell surface mediated by metal ions? How is that association 
process related to
 
membrane oxidation stress and the progression of AD disease? Driven 
by these appealing questions, we decided to further study the function of copper ions in 
Aβ assembly at membrane surface. 
Recently, we have developed a fluorescence assay to investigate the 
formation/dissociation of the Cu
2+
-PS complex in lipid membranes by a fluorescence 
quenching/dequenching detection (Chapter II).
45
 As one of the most abundant 
negatively-charged lipids in humans, PS preferentially resides in the inner leaflet of 
plasma membrane facing cytosol.
2
 The externalized PS is regarded as an essential 
marker in the recognition and clearance of apoptotic cells.
2,21,24
 Our results showed that 
Cu
2+
 can tightly bind PS in lipid bilayers and the apparent equilibrium dissociation 
constant is highly dependent upon the PS densities in supported lipid bilayers (SLBs) 
(shown in Chapter II and III). The consequence of this interaction is probably more 
remarkable when PS lipids are flipped from the inner to outer leaflet of plasma 
membranes during apoptosis. Given previous observations of the apoptotic neuron cells 
in AD brains by several groups,
133,136-138
 cellular membranes containing PS-Cu
2+
 
complex might play significant roles in the formation of Aβ deposits as well as the lipid 
 
 
61 
 
oxidation neurotoxicity since PS-enriched membrane might promote localized 
accumulation of Cu
2+
 and become a copper supply for Aβ. 
Herein we employed a combined technique of fluorescence microscopy and mass 
spectrometry to explore if Cu
2+
 can be “stolen” by Aβ from PS lipids in the membrane 
(Scheme shown in Figure 4.1). To the best of our knowledge, there are few previous 
reports of such ternary interaction of Aβ-metal ion-membrane on surface while most of 
the studies are focused upon the ion channels formed by Aβ within the 
membranes.
135,139,140
 Using our newly-developed fluorescence quenching assay based on 
a microfluidic platform, the transfer of Cu
2+ 
from PS in supported lipid bilayers (SLBs) 
to Aβ was detected by measuring the fluorescence intensity recovery after the quenching 
caused by PS-Cu
2+
 complex. Since the fluorophores were embedded in the SLBs to 
monitor the fluorescence signals affected by the nearby binding/unbinding events, this 
fluorescence-based assay enables a high-throughput label-free detection of native Aβ 
peptides and how they interact with membranes. These interactions can be further 
characterized and confirmed by electrospray ionization-mass spectrometry (ESI-MS). 
The MS spectra verified the formation of the Aβ-Cu2+ complex as well as the 
dissociation of PS-Cu
2+
 complex. It should be noted that we used Aβ1-16 and Aβ1-42 as our 
model peptides. The shorter one Aβ1-16 preserves the Cu
2+
-binding sites but excludes the 
hydrophobic domain in other longer Aβ peptides such as Aβ1-40 and Aβ1-42.
141-143
 As will 
be shown, our results reveal that, in fact, they share similar ability to bind Cu
2+
 and 
swipe them off the lipid surface. There is no need for Aβ to partition into the membrane 
to abstract Cu
2+
, which might assist clarifying this peptide-membrane interaction 
 
 
62 
 
pathway. It will also help us achieve a better understanding about how apoptosis 
participate in these chronic diseases such as AD. 
 
Figure 4.1. Schematic diagram of the proposed mechanism of Aβ-Cu2+-membrane 
interactions. In AD brain tissues, PS lipids in plasma membrane probably serve as Cu
2+
 
reservoir as they have fairly high binding affinity to trap Cu
2+
.
 Thus Aβ needs to “steal” 
Cu
2+
 from PS, which might facilitate Aβ oligomerization. The “stealing” process can be 
monitored by a combination of fluorescence quenching assay and mass spectrometry: (A) 
when Cu
2+
 binds PS in lipid bilayers, the resulting Cu
2+
-PS complex quenches the 
nearby lipid-bound fluorophore while the fluorescence can be recovered when Aβ 
swipes Cu
2+ 
from PS. (B) ESI-MS spectra also prove the formation of the Aβ-Cu2+ 
complex along with the dissociation of Cu
2+
-PS complex. 
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Experimental Section 
  
Materials 
The lipids, the buffer and the microfluidic device used in fluorescence 
experiments in this chapter were listed and described in Chapter II. The vesicles used for 
mass spectrometry experiments were prepared and stored in 10 mM ammonium acetate 
buffer. The pH of this buffer solution was adjusted to 7.4 by dropwise addition of 30% 
ammonium hydroxide solution.  Tris, NaCl, HCl, ammonium acetate, ammonium 
hydroxide and CuCl2 were purchased from Sigma-Aldrich (St. Louis, MO). Aβ1-16 and 
Aβ1-42 were purchased from AnaSpec Inc. (Fremont, CA) in lyophilized powder form. 
Aβ1-16 was dissolved in 18 MΩ•cm ultrapure water at 0.5 mg/mL, aliquoted out and 
stored at -80 °C. Then these stock solutions were diluted by 1 mM Tris buffer to 1 μM 
upon using. Aβ1-42 was dissolved in 1,1,1,3,3,3-hexafluoro-2-isopropanol (HFIP) at 0.5 
mg/mL, aliquoted out and stored at -20 °C. Immediately prior to use, HFIP was 
evaporated, and the peptides were redissolved in 1 mM Tris buffer at concentrations of 1 
μM.  
 
Vesicle Preparation, Microfluidic Device Fabrication and Bilayer Formation 
The experiment methods for preparing small unilamellar vesicles (SUVs), 
fabricating microfluidic devices and forming lipid bilayers in the devices were all 
described in Chapter II. 
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Monitoring Aβ-Cu2+-PS Interactions through Fluorescence Microscopy
Fluorescence quenching/dequenching measurements of SLBs were performed 
inside the microfluidic devices described above. The experiment set-up scheme is shown 
in Figure 1.2. 1 mM Tris buffer solution (pH 7.4) containing 1 μM CuCl2 was provided 
by supply tubes (Teflon tubing with 0.6 mm internal diameter, SPC Technology) to 
individual channels of the microfluidic device through each inlet port. The flow through 
the device was gravity driven with an average flow rate at ~100 μL/h in each 
microfluidic channel. The fluorescence of each channel was intermittently monitored by 
an inverted epifluorescence Nikon Eclipse TE2000-U microscope until equilibrium was 
reached. Then, the flow direction was reversed by switching the inlet and outlet ports. 1 
μM Aβ1-16 or Aβ1-42 in 1 mM Tris buffer was injected into the channels through outlet 
ports and the pipette tips filled with Aβ solutions were left at the outlet ports. The 
original inlet supply tubes and supply solution were subsequently laid to a level which is 
lower than the device to cause a reverse flow driving force. In this way, Aβ1-16 solutions 
were flowed into the channels at an average rate of 70 μL/h. The fluorescent images of 
the channels were captured by a MicroMax 1024 CCD camera (Princeton Instruments) 
and collected by MetaMorph software (Universal Imaging). 
Characterization of PS-Cu
2+
 Complex and Aβ-Cu2+ Complex by ESI-MS
The ESI-MS spectra of all the samples in this paper were acquired on a Waters 
Synapt HDMS G2 mass spectrometer (Waters UK Ltd., Manchester, U.K.). The samples 
were first prepared in 10 mM ammonium acetate buffer at pH=7.4 and then diluted by 
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100 times in 20 vol % methanol in water immediately before MS experiments. When 
preparing the SUVs with Cu
2+
 for the experiments, the buffer containing Cu
2+
 was used 
to re-hydrate the vacuum-dried lipids. In this way, Cu
2+
 can be distributed both inside 
and outside of the vesicles. The Cu
2+
 concentration in the buffer is half of the 
concentration of the PS in vesicles which can make it saturated at Cu(PS)2 complex. 
Negatively charged ions were formed by nano-ESI using a source temperature of ∼80 °C 
and a capillary voltage of -1.8−2.0 kV. The sampling cone voltage was set at 25 kV and 
the extraction cone voltage was 2.0 kV.  
 
Results and Discussions 
  
Firstly, the ability of Aβ to swipe Cu
2+ 
from lipid bilayers containing PS was 
investigated with fluorescence quenching/dequenching method. We employed supported 
lipid bilayers (SLBs) made of 89 mol % POPC, 10 mol % POPS and 1.0 mol % lipid-
bound fluorophore Texas Red-DHPE (TR-DHPE) as a model membrane to investigate 
the ability of PS to serve as a bridge for Aβ and metal ions. Buffer containing 1 μM Cu2+ 
flowed into the channel continuously until the fluorescence signal became unchanged. 
Figure 4.2 shows the fluorescence images and line scans of SLBs containing 10 mol % 
POPS with (left channel) or without (right channel) Cu
2+
.  In the presence of 1 μM Cu2+, 
the fluorescence of TR-DHPE was quenched by ~80% but then got almost totally 
recovered after introducing 1 μM Aβ1-16 continuously while the fluorescence response of 
the channel without Cu
2+
 was uniform. It has been found previously that the quenching 
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phenomenon is attributed to the complex formation between Cu
2+
 and PS.
45
 When PS 
lipids attract Cu
2+
 from the solution to SLBs, Cu
2+
 ions accumulate close to the bilayer 
surface, thus quenching the fluorophores nearby. The quenched fraction of the 
fluorophores reflects the Cu
2+
-PS binding. This quenching process can be reversibly 
recovered by using low pH buffer or strong metal ion-binding ligands such as 
ethylenediaminetetraacetic acid (EDTA) and nitrilotriacetic acid (NTA) to swipe off 
Cu
2+
, which inspired us to create a label-free detection of Aβ. A variety of approaches 
have shown that Aβ peptides can bind Cu
2+
 via three histidine residues and N-
terminus
36,143
 while previous reports reveal comparable binding constants for the binding 
between Cu
2+
 and Aβ1-16, Aβ1-40 or Aβ1-42, indicating that these peptides share the same 
Cu
2+
 binding region which is located in N-terminal hydrophilic portion.
127,144
 The 
measured binding constant for Aβ1-16 and Cu
2+
 is around nM
-1
.
127,144-147
 The binding 
affinity of Aβ-Cu2+ is stronger than the intrinsic affinity of PS-Cu2+ interaction (10-7 to 
10
-8
 M, shown in Chapter III). Since Aβ1-16 was continuously flowed over the lipid 
bilayer surface, it pushed the equilibrium towards the dissociation of PS-Cu
2+
 complex 
along with the association of Aβ-Cu2+, which enables it to competitively swipe Cu2+ 
from PS in SLBs visualized by fluorescence quenching recovery. This flowing assay is 
well representative of what possibly happened on cell surface. Free Aβ monomers are 
continuously generated from the amyloid precursor protein (APP) and upon forming 
complex with Cu
2+
, they tend to form oligomers or fibril aggregates, resulting in an 
overall free Cu
2+
 reduction.  
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Figure 4.2. (A) Fluorescence images and (B) line scans from two parallel microfluidic 
channels with Cu
2+
 and Aβ1-16. These two channels have 1 μM (left channel) and 0 μM 
(right channel) CuCl2 introduced. The SLBs in these two channels both consist of 10 
mol % POPS, 89 mol % POPC and 1.0 mol % TR-DHPE. The fluorescence is shown 
both before and after incubation with continuously flowing 1 μM Aβ1-16 in 1 mM Tris 
buffer at pH 7.4 for about 2 hours.  
 
To explore the process of Aβ-Cu2+-PS interaction, the time course of changes in 
fluorescence signals was subsequently shown in Figure 4.3, which also verifies that the 
dequenching issue was caused by Cu
2+
 detachment from the SLBs instead of other 
interactions between peptides and lipid membranes. When Aβ is previously saturated 
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with Cu
2+
, it will lose the ability to bind Cu
2+
 thus losing the effect on fluorescence 
signals. As shown in the pink region of Figure 4.3, the fluorescence of TR-DHPE 
embedded in SLBs was firstly quenched by 75% or 85% in the presence of Cu
2+
 at 5.0 
mol % or 15 mol % PS concentrations. However, upon introducing metal-free Aβ into 
the channels, the fluorescence signal got recovered gradually to the original intensity 
without Cu
2+
 (black and red plots in the yellow region of Figure 4.3). As a comparison, 
when Aβ flowed in together with the same concentration of Cu2+, the quenched 
fluorescence level remained intact (blue and green plots in the yellow region of Figure 
4.3). As indicated by previous studies, Aβ can employ His6, His13, His14 and Asp1 to 
bind Cu
2+
 in 1:1 stoichiometry.
141,142
 When Aβ is already Cu
2+
-saturated, there are no 
extra binding sites available on these Aβ for copper ions, leaving copper ions as Cu2+-PS 
complex on the membrane without a dequenching process. Moreover, the kinetics of this 
“stealing” Cu2+ process was also revealed by comparison of the fluorescence response 
from different PS mol % over time, e.g. 5.0 mol % and 15 mol % PS in Figure 4.3. For 
SLBs containing 5.0 mol % PS (black plot), it took about 1.5 hour for Aβ1-16 to remove 
all the Cu
2+ 
and restore the maximum fluorescence intensity. When it comes to 15 mol % 
PS condition (red plot), the recovery time is elongated to around 2.5 hours. The time 
scale to dequench by Aβ (in hours) is longer than that to quench the fluorescence by the 
same concentration of Cu
2+
 (in minutes). These results suggest that this Cu
2+
-transfer 
event is a much slower process compared with Cu
2+
-PS binding and the competence of 
Aβ over PS turns out to be weakened with an increasing PS density. During this process, 
Aβ peptides need to push the equilibrium towards the dissociation of PS-Cu2+ complex 
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along with the association of Aβ-Cu2+. It was found in our previous report that with an 
increasing surface PS concentration, the binding affinity between PS and Cu
2+
 was 
greatly enhanced (Chapter III), which might slow down the rate of Aβ to swipe Cu2+ 
from the surface, since the apparent driving force (the binding affinity difference 
between Aβ-Cu2+ complex and PS-Cu2+ complex) deteriorates significantly.  
Figure 4.3. Fluorescence response over time showing fluorescence dequenching caused 
by Aβ swiping Cu2+. POPC SLBs containing 1.0 mol % TR-DHPE and 5.0 or 15 mol % 
POPS were firstly incubated with 1 μM Cu2+ (pink background), followed by 1 μM Aβ1-
16 without or with 1 μM Cu
2+ 
(yellow background). The black and red data plots showed 
the conditions where 1 μM Aβ1-16 was introduced into SLBs containing 5.0 or 15 mol % 
POPS while the blue and green data plots showed the conditions where 1 μM Aβ1-16 was 
applied with 1 μM Cu2+. The experiments were performed in 1 mM Tris buffer at pH 7.4. 
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In the next set of experiments, the multi-channel microfluidic device containing 
SLBs with various PS mol % was applied to mimic biological environments with 
different PS densities at cell surface. Buffer containing 1 μM Cu2+ was introduced into 
the SLBs containing 0, 3.0, 5.0, 7.5, 10, 15 and 20 mol % POPS, which were then rinsed 
by 1 μM Aβ1-16. A graphical summary of the results was shown in Figure 4.4. 
Normalized fluorescence intensities after quenching at the indicated PS percentage were 
plotted in black columns and the fluorescence signals after dequenching by 1 μM Aβ1-16 
were shown in gray. It can be seen that the degree of quenching caused by Cu
2+
 was 
enhanced with higher PS concentrations, which, as expected, is consistent with an 
increasing number of Cu
2+
-PS complex as effective quenchers and a lower dynamic 
distance between the quenchers and lipid-bound fluorophores. After a continuous flow 
of Aβ1-16 solution, the quenched fluorescence was able to recover completely for most 
conditions, except for 15 or 20 mol % PS, in which the average final fluorescence signal 
reached 95% or 90% of the original intensity and the error bars showed more uncertainty 
in this range. This is probably because of the background Cu
2+
 contamination in buffer 
solutions, as discussed in our previous paper (Chapter III). To validate this assumption, 1 
nM EDTA was added into Aβ1-16 solutions to chelate the background heavy metal ions 
and a full recovery in fluorescence intensity was observed for 15 and 20 mol % PS 
conditions. Therefore Aβ swiping is effective for all these conditions with various PS 
surface densities.  
To compare with Aβ1-16, Aβ1-42 peptides were also tested, which gave us similar 
fluorescence change results. (Figure 4.5) We also tested if Aβ can stick around the 
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membrane after swiping Cu
2+
 from the PS by applying HiLyte Fluor 488-labeled Aβ1-16 
and Aβ1-42 to the SLBs containing 10 to 20 mol % PS. However, by monitoring the fluor-
tagged Aβ using total internal reflection fluorescence microscope (TIRFM), there was 
little if any peptide insertion observed. These results suggest that although the three 
negative charges of Aβ attenuate upon Cu2+ binding, it might still be repelled from the 
negatively-charged surface owing to the remaining negative charges on Aβ. The 
formation of lipid raft or domain probably can help the peptide insertion by hydrophobic 
interactions.
128,148
     
Although the apparent binding affinity for Cu
2+
 to the SLBs containing 7.5~20 
mol % PS (sub nM ~ pM scale) is stronger than Aβ-Cu2+ (nM scale), the tight apparent 
binding affinity between Cu
2+
 and PS is indeed caused by the increased Cu
2+
 
concentration in double layer of the negatively-charged surface due to Coulombic effect. 
The surface charge-adjusted intrinsic binding affinity of PS to Cu
2+ 
turns out to be 
weaker than Aβ. (Chapter III) Therefore, Aβ peptides are able to steal copper ions by a 
continuous approach to the membrane to alter the binding equilibrium.  
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Figure 4.4. The graphic summary of normalized fluorescence intensity of SLBs 
containing PS with Cu
2+
-quenching and Aβ1-16 dequenching. The POPC SLBs contained 
0 to 20 mol % POPS and 1.0 mol % TR-DHPE. The black columns were plotted as the 
normalized fluorescence intensities after buffer containing 1 μM Cu2+ flowed into the 
channels and caused quenching at the indicated PS percentage and the gray columns 
were the fluorescence signals after dequenching by 1 μM Aβ1-16. The error bars represent 
the standard deviation of three to five experiments. 
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Figure 4.5. The graphic summary of normalized fluorescence intensity showing Aβ1-42 
has the similar ability to grab Cu
2+
 compared with Aβ1-16. The black columns were 
plotted as the normalized fluorescence intensities from POPC SLBs containing 0 to 20 
mol % POPS and 1.0 mol % TR-DHPE observed after quenching by 1 μM Cu2+-
quenching at the indicated PS percentages and the gray columns were the fluorescence 
signals after dequenching by 1 μM Aβ1-42. The error bars represent the standard 
deviation of three to five measurements. 
 
Finally, ESI-MS was utilized as a supplementary label-free method to reveal the 
identification of the complexes during this association/dissociation process. Given the 
ability of ESI-MS to manipulate large intact molecular ions through soft ionization mode, 
the copper transfer from lipids to peptides can be examined in a more straight-forward 
way by capturing the declining peaks of PS-Cu
2+ 
complex along with the rising peaks of 
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Aβ-Cu2+ complex in mass spectra. In the mass spectra shown in Figure 4.6, the specific 
m/z signals of PS and the Cu(PS)2 complex were highlighted in pink background while 
the Aβ1-16 and their corresponding Cu
2+
-bound complexes were highlighted in blue. As 
can be seen, when the vesicles containing 20 mol % POPS were extruded with Cu
2+ 
(Figure 4.6B), the extra peaks corresponding to [2POPS+Cu]
2- 
ions
 
(m/z = 791) can be 
observed compared with the vesicles without Cu
2+
 (Figure 4.6A). This is consistent with 
our previously-built model (binding reaction shown in Figure 3.1). When Cu
2+
 reacts 
with PS molecules, it preferentially binds the amine and carboxyl groups and forms a 
square-planar complex in which one proton on each of the two amine groups is displaced 
(Chapter III). As such, the 2POPS-Cu
2+
 complex possess two negative charges, which is 
confirmed by the negative mode mass spectra here. These characteristic peaks 
significantly diminished in Figure 4.6C when Aβ1-16 was present to compete with PS for 
Cu
2+
 binding, while simultaneously the peaks corresponding to [Aβ+Cu]3- and 
[Aβ+Cu]2- appeared.  
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Figure 4.6. The negative mode ESI-MS spectra of PS-contained vesicles with CuCl2 and 
Aβ1-16. The vesicles were 1 mM 80 mol % POPC /20 mol % POPS vesicles (A) extruded 
without CuCl2; (B) extruded with CuCl2 (molar ratio of PS: Cu
2+
 = 2:1); (C) extruded 
with CuCl2 and then incubated with 100 μM Aβ1-16 for 2 hours. All the samples were 
firstly prepared in 10 mM ammonium acetate buffer and then diluted by 100 times in 20 
vol % methanol in water solvent for MS exp. The PS and Cu(PS)2 peaks are highlighted 
in pink background while the Aβ and Aβ-Cu2+ peaks are highlighted in blue background. 
 
Since the depression of MS signals of the Cu
2+
-PS complex occurs along with the 
emergence of the Aβ-Cu2+ complex signals, it also suggests that these complexes are 
formed by specific binding instead of non-specific interactions when they are sent into 
MS system, which further indicates the high stability of these complexes. Overall, these 
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spectra correlate well with the fluorescence quenching/dequenching process and validate 
the transfer of Cu
2+
 from PS lipids to Aβ peptides.   
 
Conclusion 
 
In conclusion, the combination of fluorescence microscopy, microfluidic 
technique and mass spectrometry offers us a unique platform to mimic how Aβ peptides 
approach cell membranes and obtain metal ions in neural systems. The results indicate 
that plasma membranes with exposed PS probably provide Cu
2+
 as stimulates or medium 
for the Aβ oligomerization and assist the seeding of Aβ deposits on cell surfaces. It is 
possible that with an additional hydrophobic domain, the longer Aβ peptides such as 
Aβ1-40 or Aβ1-42 might be involved in further interactions, for example, inserting into 
lipid rafts to form ion channels,
132,149
 which will be studied in the future. The multi-
technique label-free method described here could be extended to the analysis of more 
membrane-related proteins or peptides to obtain useful biological information about the 
membrane-ion-protein/peptide interactions. 
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CHAPTER V 
THE EFFECTS OF Cu
2+
-PHOSPHATIDYLSERINE BINDING ON LIPID 
OXIDATIONS  
 
Introduction 
 
Lipid oxidations have been regarded as important factors contributing to a variety 
of physiological and pathological events such as cell apoptosis, atherosclerosis and 
Alzheimer's disease.
150-154
 It is typically induced by partial oxidation by reactive oxygen 
species (ROS) such as O2, O2
-
 and H2O2, which further brings about cellular dysfunction, 
enzyme inactivation and DNA damage.
155
 It has long been known that the 
polyunsaturated fatty acids (PUFA) can decompose due to the slow autoxidation during 
storage.
156-158
 The reactions are usually initiated by the hydrogen abstraction from allylic 
or bis-allylic positions. The activate methylene group adjacent to the double bonds 
represents a critical target site where the hydrogen abstraction is easy to be 
achieved.
157,158
 This initiation reaction subsequently leads to an oxygenation and the 
formation of peroxyl radicals as well as the following propagation steps. These chain 
reactions are likely to be catalyzed by transition metal ions.
157-159
 Through a similar 
pathway, the autoxidation of phospholipids with polyunsaturated acyl chains should take 
place as well in biological systems, which can cause the destruction of cell membranes. 
These autoxidation processes usually involve the formation of lipid radicals, oxygen 
uptake, rearrangement of the double bonds in unsaturated acyl chains and further 
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transformations to generate products such as alcohols, ketones, aldehydes and carboxylic 
acids.
157,160
  
Transition metal ions in human body are bound to proteins, membranes and other 
cell constituents and their distribution is strictly regulated by metallochaperones.
32
 
Among these ions, the redox-active iron and copper can catalyze the redox-cycling by 
reducing the induction period and increasing the rate of lipid oxidation. It has been 
proposed that the interactions of iron and copper ions with O2 or H2O2 can generate the 
destructive oxidants O2
- 
or •OH through Fenton reactions or Harber-Weiss reactions.
161-163
 
The presence of chelating agents may promote or inhibit metal-ion-dependent ROS 
formation, depending on a number of factors such as the solubility of the complex, the 
redox potential of the M
n+
/M
(n-1)+
 pair and whether or not it has a free coordination 
site.
161,162,164
 As the third most abundant transition metal ions in human systems, copper 
has a overall concentration (complexed and free) of ~100 μM in common tissues while 
the concentration of uncomplexed copper in the cytoplasm is extremely low (~10
-18 
M).
67
 
However, high concentrations of copper (mM scale) have been detected in the amyloid 
plaques, one of the well-recognized pathologies present in Alzheimer’s disease (AD) 
patients’ brains.165 In contrast, total Cu2+ concentration is generally reported to decrease 
in AD brain tissues, probably because Cu
2+
 is abnormally redistributed, leading to the 
dysfunction of copper ion homeostasis.
127-129
 Moreover, the Cu
2+
 in AD brain systems 
are found accumulated in lipid rafts which are rich in anionic lipids. In consequence, 
amyloid-beta peptides (Aβ) might readily precipitate close to these regions on the 
membranes and cause further oxidative damage.
128,130,133,134,166
 In this context, it is 
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intriguing to see how the interactions of transition metal ions with different kinds of 
lipids would affect the oxidation process.  
In previous studies, we have detected the formation of the Cu
2+
-
phosphatidylserine (PS) lipid complex by a fluorescence quenching-based assay on lipid 
bilayers (Chapter II).
45
 Given this binding event, we hypothesized that the Cu
2+
 approach 
to the membrane surface may have some consequences on the oxidation rate of the 
unsaturated lipids. On one hand, when PS binds Cu
2+
 and immobilizes it at the 
headgroup moiety, it might limit the free motion and activity of Cu
2+
 to catalyze the lipid 
oxidation. On the other hand, when Cu
2+
 is attracted by PS to accumulate on the bilayers, 
the surface concentration of Cu
2+
 gets increased, which might promote the oxidation 
reaction. We wish to see how these contradictory factors contribute to lipid oxidation 
toxicity in a variety of physiological and pathological conditions.  
 
Experimental Section 
  
Materials 
The following lipids were used in these experiments. 1,2-Dilauroyl-sn-glycero-3-
phosphocholine (DLPC), 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC), 
1,2-dilauroyl-sn-glycero-3-phospho-L-serine (DLPS), 1-palmitoyl-2-linoleoyl-sn-
glycero-3-phosphocholine (PLiPC), 1-palmitoyl-2-linoleoyl-sn-glycero-3-phospho-L-
serine (PLiPS), 1,2-dilauroyl-sn-glycero-3-phospho-(1'-rac-glycerol) (DLPG), 1,2-
dilauroyl-sn-glycero-3-phosphate (DLPA) and 1,2-dilauroyl-sn-glycero-3-
80 
phosphoethanolamine (DLPE) were purchased from Avanti Polar Lipids (Alabaster, AL). 
The vesicles used for mass spectrometry experiments were prepared and stored in 10 
mM ammonium acetate buffer. The pH of the buffer was adjusted to 7.4 by dropwise 
addition of 30% ammonium hydroxide solution. The ammonium acetate, ammonium 
hydroxide, copper chloride and all the solvent (HPLC grade) used in these experiments 
were purchased from Sigma-Aldrich (St. Louis, MO). The purified water (18.2 MΩ•cm) 
used in all these experiments was acquired from a NANOpure Ultrapure Water System 
(Barnstead, Dubuque, IA). 
SUVs Preparation and Oxidation 
The experiment procedures for preparing small unilamellar vesicles (SUVs) were 
described in Chapter II. Oxidation treatments were carried out by adding Cu
2+
 into the
SUVs solutions followed by incubations. No peroxidants such as H2O2 were added into 
the system while the only applicable oxidants are atmospheric O2 dissolved in vesicle 
solution. 75 μM CuCl2 were added into the vesicle solution containing 300 μM PLiPC (1 
mM vesicles consisting of 70 mol % DLPC and 30 mol % PLiPC or 40 mol % DLPC, 30 
mol % DLPS and 30 mol % PLiPC) and this mixture was incubated at 37 ˚C for different 
time periods. 
Characterization of Oxidation Products by LC-MS and ESI-MS/MS 
The oxidation products of the unsaturated lipids were separated and characterized 
by Surveyor HPLC system (Thermo Finnigan, San Jose, CA) interfaced with quadrupole 
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ion trap mass spectrometer (LCQ-DECA; Thermo Electron). The reaction products were 
diluted by ten times in methanol and then introduced into a Phenomenex 2.6 μm C8 
column (150 x 2.1 mm, kept at 55˚C). The mobile phase consisted of acetonitrile-
aqueous ammonia formate (5 mM; 60:40; eluent A) and isopropanol-acetonitrile 
containing ammonia formate (5 mM; 90:10; eluent B). The solvent gradient was 
programmed as follows: 10% B for 3 min followed by linear increase to 50% B at 10 
min and then increase linearly to 66% B at 15 min and subsequently increase linearly to 
97% B at 19 min and held isocratically for 4 min and then back to 10% B for 7 min. The 
flow rate was 200 μL/min. The ESI-MS/MS spectra of the SUVs solutions were acquired 
on a Waters Synapt HDMS G2 mass spectrometer (Waters UK Ltd., Manchester, U.K.). 
The samples were first prepared in 10 mM ammonium acetate buffer at pH=7.4 and then 
diluted by 100 times in 20 vol % methanol in water immediately before MS experiments. 
The diluted samples were directly infused into the mass spectrometer at a rate of 0.5−0.8 
μL/min and the ions were formed by nano-ESI using a source temperature of ∼100 °C 
and an inlet capillary voltage of 1.8~2.0 kV. The sampling cone voltage was set at 25 kV 
and the extraction cone voltage was 4.0 kV. All fragmentation was carried out by 
collision of ions with background gas (argon) and the collision energy for collision 
induced dissociation (CID) of the phospholipids was generally set in a range of 28~40 V.  
To compare the extent of oxidation in various samples, the relative oxidation 
amounts can be determined by looking at the disappearance of starting materials, the 
unsaturated lipid PLiPC with two double bonds. Two kinds of internal standards, DLPC 
and POPC, were used in this relative quantification method. DLPC was already present 
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in the vesicles as the main component of the vesicles while POPC could be added into 
the system before dilution and loading into LC-MS. The response of the target lipids is 
normalized to the response of the two standard lipids separately, which gave similar 
results. The unoxidized percentage of the PLiPC can be calculated as:  
    
  
    
    
    
                                                   (5.1) 
where Ar is the LC peak area of PLiPC in oxidized vesicle solutions while Aori is the 
area of PLiPC in original (unoxidized) vesicle solution; Astd is the area of standard 
(DLPC or POPC) in oxidized solution while A’std is the area of that standard in 
unoxidized solution. The relative oxidation extent can be calculated as: 
                                                            (5.2) 
 
Results and Discussions 
 
Cu
2+
-catalyzed PLiPC Oxidation 
After incubating with Cu
2+
 for different periods of time, the LC-MS 
chromatograms of vesicles consisting of 70 mol % DLPC and 30 mol % PLiPC with the 
internal standard POPC are obtained. Since the ESI-MS spectra of PC lipids usually 
share a characteristic phosphocholine head group peak at m/z=184,
167
 the reconstructed-
ion chromatograms (RIC) of the PC lipids with peaks at m/z = 184 were shown in Figure 
5.1 to rule out the background contaminates for a more accurate quantification. As 
observed in Figure 5.1, the retention time of the non-oxidized standards DLPC and 
POPC lipids was around 9.6 min and 14.7 min, respectively, while the non-oxidized 
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target lipids PLiPC was eluted at 13.9 min. The corresponding MS spectra of these LC 
peaks showed the presence of characteristic molecular ions and the sodium adducts 
([M+H]
+ 
and [M+Na]
+ 
) of DLPC (m/z 622 and 644), POPC (m/z 760 and 782) and 
PLiPC (m/z 758 and 780). The chromatographic results reveal that the elution time of 
PC lipids increases when the molecule is more lipophilic, i.e. with longer acyl chains and 
fewer double bonds present. The oxidation products of PLiPC obtained after various 
incubation times were also shown in the RIC figure by a number of peaks evolved with 
retention times from 3 to 14 min, which correspond to multiple oxidation products. In 
the linoleic acyl chain of PLiPC, there are several vulnerable sites for oxidation reactions. 
The two double bonds at C-9 and C-12 present in the linoleic acyl chain can stabilize the 
radical intermediates at their allylic positions due to conjugation effects, thus favoring 
the hydrogen extraction at these positions. The lost of bis-allylic hydrogen on C-11 can 
generate the alkyl radical, which will be stabilized by rearrangement of the two double 
bonds to form a conjugated diene radical centered at C-9 or C-13 (mechanism shown in 
Figure 5.2). Such radical species are able to uptake O2 to create peroxyl radicals and 
eventually produce long-chain oxidation products by insertion of oxygen atoms. On the 
other hand, the initially-oxidized polyunsaturated acyl groups can undergo 
intramolecular rearrangement reactions or further oxidation to generate chain-shortened 
products such as alcohols, aldehydes or carboxylic acids.
168,169
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Figure 5.1. The reconstructed-ion chromatograms (RIC) of the vesicles containing 70 
mol % DLPC and 30 mol % PLiPC incubated with Cu
2+
 over different time periods. 75 
μM CuCl2 was added into the 1 mM vesicle solution and incubated in 37 ˚C for different 
hours. The samples were then diluted in methanol by ten times and 10 μM POPC was 
added as an internal standard before LC-MS experiments. The RIC of the PC lipids were 
generated based on a characteristic MS peak of PC lipids (m/z = 184) to rule out the 
background contaminates. 
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Figure 5.2. The proposed formation mechanism of PLiPC radicals susceptible to 
oxidations. PLiPC has two double bonds at C-9 and C-12 in the sn-2 linoleic acyl chain 
where the hydrogen extraction readily happens. The lost of bis-allylic hydrogen on C-11 
generates the alkyl radical, which will be further stabilized by rearrangement of the two 
double bonds to form a conjugated diene radical centered at C-9 or C-13. 
 
 
It is interesting to find that these long-chain and short-chain oxidation products 
exhibit different ionization efficiency, shown in Figure 5.1. After incubating with Cu
2+
 
for 6 hours (Figure 5.1B), the predominant long-chain oxidation products were found to 
be eluted at 11.0, 11.1 and 11.3 min. The mass spectra of these peaks show the ions with 
m/z equal to 794, 796 and 812, which correspond to the sodium adducts of long-chain 
oxidation products, 1-palmitoyl-2-(keto-octadecadienoic acid)-sn-glycero-3-
phosphocholine, 1-palmitoyl-2-(hydroxy-octadecadienoic acid)-sn-glycero-3-
phosphocholine and 1-palmitoyl-2-(hydroperoxide-octadecadienoic acid)-sn-glycero-3-
phosphocholine, respectively. Possible structures of the oxidation products were certified 
by comparing their ESI-MS/MS spectra with the previous reports and they were listed in 
Table 5.1.
168,170
 However, after 12 to 24 hours’ incubation time (Figure 5.1C-E), the 
Hydrogen abstraction
Rearrangement
-H -H
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peak areas of these long-chain products decrease and we observed the appearance of 
broad peaks of the sodium adducts of short-chain oxidation products including 1-
palmitoyl-2-(8-oxo-octanoic acid)-sn-glycero-3-phosphocholine (m/z = 658), 1-
palmitoyl-2-(9-oxo-nonanoic acid)-sn-glycero-3-phosphocholine (m/z = 672), 1-
palmitoyl-2-(nonandioic acid)-sn-glycero-3-phosphocholine (m/z = 688), 1-palmitoyl-2-
(9-keto-12-oxo-10-dodecenoic acid)-sn-glycero-3-phosphocholine (m/z = 726), 1-
palmitoyl-2-(9-keto-10-dodecendioic acid)-sn-glycero-3-phosphocholine (m/z = 742)  
and 1-palmitoyl-2-(9-hydroxy-10-dodecendioic acid)-sn-glycero-3-phosphocholine (m/z 
= 744), etc, which were also found in previous lipid peroxidation research (also listed in 
Table 5.1).
171
 These short-chain products are more hydrophilic than the long-chain ones 
and eluted out of the LC column faster in a more aqueous solvent mixture, which might 
explain why they present lower ionization efficiency. These phenomena were also 
observed in previous reports by other groups although the detailed mechanism remains 
unclear.
51,168
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Table 5.1. Oxidation products and their possible structures 
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To validate that free Cu
2+
 was able to catalyze the oxidation in general and the 
oxidation of PLiPC occurred via a radical-related mechanism, two control experiments 
were performed, as shown in Figure 5.3. When EDTA instead of Cu
2+ 
was added into the 
vesicle solution and incubated for 24 hours, the detected oxidation level was low (< 10%) 
in Figure 5.3A. The addition of EDTA chelated the unavoidable trace amounts of Cu
2+
 
in contaminates found in buffer solutions and experiment apparatus (Chapter III) and 
could significantly inhibit the oxidation reactions. To further study the mechanism of 
autoxidation, a free radical scavenger was tested as an additive in this system. Herein 
butylated-hydroxytoluene (BHT) was applied as the radical-capturing agent.
172
 
Compared with the results obtained from the samples without BHT in Figure 5.1E, there 
was little oxidation found in Figure 5.3B, which implied that the oxidation was through a 
free radical-mediated pathway. With radicals being scavenged by BHT, the autoxidation 
of polyunsaturated lipids are inhibited, even in the presence of copper ions.  
 
 
89 
 
 
Figure 5.3. The RIC of the vesicles containing 70 mol % DLPC and 30 mol % PLiPC 
incubated for 24 hours without Cu
2+ 
or with Cu
2+
 and BHT. The vesicles were made at 1 
mM total lipid concentration in 10 mM ammonium acetate buffer at pH = 7.4. In (A), 75 
μM EDTA was added into the vesicle solution while in (B), 75 μM CuCl2 and 75 μM 
BHT were added into the vesicle solution simultaneously. These two samples were both 
incubated in 37 ˚C for 24 hours.  
 
Cu
2+
-PS Binding Inhibits Cu
2+
-catalyzed PLiPC Oxidation 
In a next set of experiments, PS lipids were introduced into the vesicles to 
explore their effects on Cu
2+
-promoted PLiPC autoxidation. Vesicles containing 40 mol % 
DLPC, 30 mol % DLPS and 30 mol % PLiPC were compared with the ones with 70 mol % 
DLPC and 30 mol % PLiPC after incubating with the same Cu
2+
 concentrations for 
different times. The LC-MS of each condition was acquired and the oxidation 
percentages of PLiPC were calculated and plotted in Figure 5.4 as a function of 
incubation time. As shown in Figure 5.4, the oxidation extent of PLiPC without PS 
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significantly increased to about 85% when the incubation time was extended to 24 hours. 
However, in the presence of 30 mol % DLPS in the vesicles, the PLiPC oxidation 
remarkably slowed down while only 20% of the PLiPC got oxidized after incubation 
with Cu
2+ 
for the same amount of time. This difference in oxidation rate was more 
obvious in the right panel of Figure 5.3, where the LC peaks of our target lipid PLiPC 
and the internal standard lipid POPC were compared for two kinds of vesicles after 
different incubation time. For the vesicles without PS, the PLiPC peaks shrink rapidly 
with time going, which is far more pronounced than the PS-containing vesicles. These 
results indicate that the Cu
2+
-PS binding might have inhibitory effects on Cu
2+
 catalysis 
of autoxidation of the surrounding unsaturated lipids. On one hand, the Cu
2+
-binding of 
PS headgroups might shift the redox potential of Cu
2+
/Cu
+
.
173
 After the carboxyl and 
amino groups from two PS lipids chelate Cu
2+
 and form a stable square-planar complex, 
it is more difficult to reduce Cu
2+ 
to Cu
+ 
as the ligand field-stabilized Cu
2+
 might no 
longer be an active electron acceptor in the redox cycling.
173
 On the other hand, when 
Cu
2+
 ions were localized at the headgroup region of lipid bilayers, they were restricted 
from diffusing in solution or membranes so that the direct activation of the allylic 
hydrogen of the double bond was less likely to occur. Therefore, the oxidative damage 
of surrounding unsaturated lipids was attenuated.      
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Figure 5.4. A comparison of the oxidation percentages of vesicles without or with PS 
over time. The vesicles noted as “DLPC/PLiPC” consist of 70 mol % DLPC and 30 mol % 
PLiPC while the vesicles labeled as “DLPC/DLPS/PLiPC” contain 40 mol % DLPC, 30 
mol % DLPS and 30 mol % PLiPC. They were both made at 1 mM total lipid 
concentration in 10 mM ammonium acetate buffer at pH = 7.4. After incubation with 75 
μM CuCl2 for different time periods, the samples were diluted in methanol by ten times 
and 10 μM POPC was added as an internal standard before the LC-MS was applied. In 
the left panel, the oxidation percentage was plotted as a function of incubation time. The 
error bars represent the standard deviation of multiple measurements. In the right panel, 
the LC peaks of PLiPC (peak on the left) and the internal standard POPC (peak on the 
right) from the two different vesicle solutions were shown side by side to give a clearer 
presentation for comparison.   
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Comparisons of PS with Other Lipids  
The interactions between anionic lipids and transition metal ions have been 
explored before for their effects on the lipid peroxidation.
39,174
 It was found that the 
negatively-charged lipids such as PS and PA effectively inhibited lipid peroxidation 
induced by iron or copper ions, which was ascribed to their binding of free iron/copper 
ions. However, there were no comparisons between different anionic lipids and the 
oxidation levels reported in these papers were generally measured by UV spectra, which 
was not the optimal technique to quantify all the generated oxidation products. Moreover, 
although the main focus of these reports are about the lipid peroxidation induced by 2,2'-
azobis(2-amidinopropane) dihydrochloride (AAPH) or ascorbic acid (AA), the 
autoxidation process cannot be ruled out and it is hard to differentiate these complicated 
oxidation pathways. Therefore, questions and doubts still remain about the inhibitory 
effect of the anionic lipids on the lipid oxidation. Our discovery of the specific binding 
between PS and Cu
2+ 
instead of an electrostatic attraction encouraged us to believe that 
PS might behave differently when compared with the other anionic lipids.    
Here a variety of phospholipids were mixed with PLiPC in vesicles to compare 
their efficacy against oxidation damage.  The vesicle containing 70 mol % DLPC and 30 
mol % PLiPC incubated with Cu
2+
 for 24 hours served as a control, which was compared 
with the vesicles consisting of 40 mol % DLPC, 30 mol % PLiPC and 30 mol % DLPS, 
DLPG, DLPA or DLPE under the same conditions. A column graphic representation of 
the results as well as the structures of these lipids was shown in Figure 5.5. PS, PG and 
PA each carry one negative charge at physiological pH but PG and PA cannot 
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specifically bind Cu
2+
 with a high affinity as PS does.
45
 As illustrated by Figure 5.5, the 
oxidation percentages for different anionic lipids were in the order of: PS<PA<PG, 
which means that PS has the largest inhibitory effect due to the highest binding affinity 
of Cu
2+
. The difference between PA and PG might arise from the extra sterically 
hindered glycerol headgroup of PG that might block the Cu
2+
-phosphate group 
interaction. This is similar to their electrostatic interaction behaviors with other 
cations.
175
  As for PE, despite its zwitterionic property at physiological pH, it may bind 
metal ions through the deprotonated amine group, but only at alkaline environment. 
Therefore, under the neutral conditions used in the experiments, the addition of PE here 
showed little inhibitory effects on the PLiPC oxidations (Figure 5.5).  
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Figure 5.5. A graphic summary showing the comparison of oxidation percentages of 
PLiPC mixed with different kinds of lipids. The control samples are vesicles consisting 
of 70 mol % DLPC and 30 mol % PLiPC while the other vesicles contain 40 mol % 
DLPC, 30 mol % PLiPC and 30 mol % DLPS, DLPG, DLPA or DLPE. They were both 
made at 1 mM total lipid concentration in 10 mM ammonium acetate buffer at pH = 7.4. 
After incubation with 75 μM CuCl2 at 37 ˚C for 24 hours, the samples were diluted in 
methanol by ten times and 10 μM POPC was added as an internal standard before the 
LC-MS was applied. The oxidation percentage of each kind of vesicle was plotted and 
the error bars represent the standard deviation of multiple measurements. The structures 
of DLPS, DLPG, DLPA and DLPE were shown at the bottom.   
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Comparisons of PS with Other Cu
2+
-Binding Reagents  
Cu
2+
 is generally known to form complexes with amino acids such as glycine and 
alanine with an apparent dissociation constant of 10
-8 
M.
176
 Another common Cu
2+
-
binding ligand in metalloproteins is histidine. In neurodegenerative disorders such as 
Alzheimer’s disease, Cu2+ has been found to tightly bind Aβ peptides by three histidine 
residues and N-terminal, which promotes the Aβ aggregation.36,102 In the last set of 
experiments, some of these physiological binding reagents were employed to investigate 
their effects on lipid autoxidation. As shown in Figure 5.6, glycine and histidine were 
added into the vesicles to compare with the vesicles containing PS. After incubation with 
the same Cu
2+
 concentration for 24 hours, the oxidation percentage of PLiPC in the 
presence of histidine was found to be lower than the samples containing glycine, 
although both of them show less inhibitory effects than PS lipids (Figure 5.6). Cu
2+
 has a 
higher binding affinity for histidine than glycine owing to the imidazole nitrogen at the 
side chain of histidine as an extra coordinating group besides the amino and carboxyl 
group. This chelating effect yields an apparent dissociation constant of 10
-10 
M for Cu
2+
-
histidine binding.
176,177
  The binding affinity between Cu
2+
 and the SLBs containing 20 
mol % PS, has been measured to be around pM scale (Chapter III). It was expected that 
the lipid bilayers containing high PS densities should have a higher binding affinity for 
Cu
2+
 relative to glycine or histidine. Moreover, compared with PS anchored on the 
surface of the vesicles, the amino acid-metal ion complexes in solution are more 
accessible because of their free diffusion, which might also promote the Cu
2+
 catalysis of 
the lipid autoxidation process.  
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Figure 5.6. A graphic summary showing the comparison of oxidation percentages of 
PLiPC when different Cu
2+
-binding reagents were added. The “control” samples are 
vesicles consisting of 70 mol % DLPC and 30 mol % PLiPC while the samples labeled 
as “with DLPS” are vesicles contain 40 mol % DLPC, 30 mol % PLiPC and 30 mol % 
DLPS. The samples labeled as “with glycine” and “with histidine” are vesicles of 70 
mol % DLPC and 30 mol % PLiPC while 300 μM glycine or histidine was added into 
the samples, respectively. These vesicles were both made at 1 mM total lipid 
concentration in 10 mM ammonium acetate buffer at pH = 7.4. After incubation with 75 
μM CuCl2 at 37 ˚C for 24 hours, they were diluted in methanol by ten times and 10 μM 
POPC was added as an internal standard before the LC-MS was applied. The oxidation 
percentage of each kind of vesicle was plotted and the error bars represent the standard 
deviation of multiple measurements.  
 
The mechanism of the lipid autoxidation is complicated and still unclear although 
they were discovered and studied in previous reports.
157,158,160,178
 The original induction 
might involve a radical formation by hydrogen abstraction of the bis-allylic position on 
the polyunsaturated acyl chain of lipids. The heavy metal and the ROS impurity in buffer 
solutions and UV light irradiation might generate free radicals and act as the initiators 
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for radical-mediated lipid oxidation while the propagation of the chain reaction can be 
catalyzed by transition metal ions like copper. Since PS in lipid membranes has a surface 
accumulation effect for Cu
2+
 and can bind Cu
2+
 tightly, it may serve as the transition 
metal ion reservoir on cell surface and help protecting against the lipid autoxidation and 
maintaining the membrane integrity. Things might be different when the double bonds 
are on PS lipids themselves which could change the oxidation rates and pathways. 
Besides, in cell membranes, the existence of other lipids such as sphingolipids, 
cholesterol and ganglioside may also affect the interactions of PS and metal ions by 
changing the fluidity of the membranes, creating lipid rafts and causing the redistribution 
of PS on membranes,
179,180
 which will be studied in the future.    
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CHAPTER VI 
CONCLUSIONS 
 
We developed a novel fluorescence quenching assay to investigate the 
interactions between Cu
2+ 
and PS lipids in cell membranes. This assay was built upon 
lipid bilayer-coated microfluidic platforms, which could be combined with fluorescence 
microscopy and other spectroscopic techniques to detect the association/dissociation of 
Cu
2+
 and PS on SLBs. PS lipids were found to bind Cu
2+
 and the resulting Cu(PS)2 
complex was able to quench a broad spectrum of lipid-bound fluorophores in a 
reversible and pH-dependent fashion. At acidic pH values, the fluorophores are almost 
completely unquenched while at basic pH, up to 90% quenching can be achieved.  
This quenching assay can be used to determine the equilibrium dissociation 
constants between Cu
2+
 and SLBs containing different PS concentrations, since the PS 
concentration on cell surfaces varies during different biological events such as the cell 
apoptosis and blood clotting. Our results showed that with an increasing PS surface 
density from 1.0 to 20 mol %, the apparent binding affinity of PS-containing SLBs to 
Cu
2+ 
was enhanced significantly by about five orders of magnitude. This binding 
enhancement can be attributed to the accumulated large quantities of Cu
2+
 ions in the 
double layer of the negatively-charged bilayer surface as well as a switch between 
monovalent and divalent binding. When Cu
2+
 is chelated by the deprotonated amine 
groups and carboxyl groups of two PS molecules, the resulting Cu(PS)2 complex 
preserves the negatively-charged character on membranes, thus causing a remarkably 
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high concentration of Cu
2+
 close to the surface relative to the bulk solution. These results 
might provide insights into the interactions between transition metal ions and PS lipids at 
specific physiological or pathological conditions. For example, when PS flips from the 
inner to the outer leaflet of plasma membranes during cell apoptosis or other biological 
events, they will be brought into direct contact with a Cu
2+
-rich environment. With a 
significantly enhanced apparent binding affinity to Cu
2+ 
at high PS densities,
 
PS-Cu
2+
 
complexes may get involved into apoptotic process and the membrane oxidative stress or 
affect the membrane binding of PS-relevant proteins.  
In addition, this fluorescent-based detection method was further employed to 
explore the Cu
2+
-mediated interactions between proteins/peptides and membrane. It was 
combined with mass spectrometry technique to provide a label-free way to mimic how 
Aβ peptides approach to cell membranes to attain metal ions in neural systems. Our 
fluorescence and mass spectra results correspond well with each other to demonstrate the 
Aβ-Cu2+-PS interactions on lipid bilayers where Cu2+ could be grabbed from PS-
containing membranes by Aβ peptides. It indicates that plasma membranes with exposed 
PS probably provide Cu
2+
 as stimulates or medium for the Aβ oligomerization on cell 
surfaces, especially when copper is deficient in AD patients’ brain systems. More 
research about the Aβ insertion into the membranes and the related oxidation damage 
will be studied in the future. Besides, this multi-technique label-free method described 
here could be extended to the analysis of more membrane-related proteins or peptides to 
obtain useful biological information about the membrane-ion-protein/peptide 
interactions. 
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Finally, LC-MS was applied to study how PS affects Cu
2+
-catalyzed lipid 
autoxidation in vesicles. The oxidation percentage of PC lipids with double bonds was 
inhibited when PS was present in the vesicles and this inhibitory effect was higher than 
the other anionic lipids and the amino acids which can also bind Cu
2+
. In this way, PS 
might be an antioxidant candidate for protecting surrounding unsaturated lipids against 
autoxidation 
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